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Synthetic   biology   (synbio)   is   a   chance   for   our   societies   to   advance  
from   oil-­‐‑dependent   to   bio-­‐‑based   production,   with   the   help   of  
microbes.   The   two   pillars   of   synbio   are   fundamental   biological  
knowledge  and  applied  engineering.  In  the  present  thesis,  these  two  
aspects  of  synbio  are  explored,  and  their  connections  described.  First,  
the   different   definitions   and   features   of   synbio   are   covered,   after  
which  two  individual  research  projects  are  reported.  
  
Evolution   is   the   basis   for   all   life   on   Earth,   and   we   are   constantly  
learning  more  about  its  mechanisms.  This  thesis  describes  important  
elements   of   evolutionary   theory,   and   in   particular   the   controversy  
surrounding   the   theory   of   adaptive   mutagenesis.   Furthermore,  
experimental   results   showing   how   adaptive   mutation   is   strongly  
associated  with  transcription  are  reported.    
  
When   constructing   cell   factories,   display   of   proteins   on   the   cell  
surface  by  using  the  cell  machinery   is  an  attractive   technology.  This  
thesis  includes  the  report  of  a  new  bacterial  surface  display  platform  
that  makes  use  of  green  fluorescent  protein  and  nanobodies  for  easy  
detection  and  evaluation  of  surface  presentation.    
  
While   representing   the   two   pillars   of   synthetic   biology,   the   two  
research  projects  presented  also   illustrate  how  every  synbio  venture  
contains   features   of   fundamental   as   well   as   applied   science.   With  
fundamental   studies   inspiring   new   engineering   efforts,   and  
application  development  enabling  further  study  of  basic  biology,  it  is  
clear  how  synbio  is  created  in  the  overlap  between  the  two.       





Syntetisk   biologi   (synbio)   er   en   mulighed   for   vores   samfund   at  
avancere   fra   oliebaseret   til   biobaseret   produktion,   ved   hjælp   af  
mikroorganismer.   Grundforskning   og   anvendelsesfokuseret  
ingeniørvidenskab  udgør  synbios  to  søjler.  I  denne  afhandling  bliver  
disse  to  aspekter  af  synbio  udforsket,  og  deres  forbindelser  beskrevet.  
Først   beskrives   de   forskellige   synbio   definitioner,   og   herefter  
præsenteres  to  individuelle  forskningsprojekter.    
  
Evolution  er  basis  for  alt  liv  på  Jorden,  og  vi  lærer  hele  tiden  mere  om  
dens  mekanismer.   Denne   afhandling   beskriver   vigtige   elementer   af  
evolutionsteori,  og  specielt  kontroversen  omkring  teorien  om  adaptiv  
mutation.   Afhandlingen   indeholder   eksperimentelle   resultater   der  
viser   hvordan   adaptive   mutationer   er   stærkt   associerede   med  
transkription.    
  
Ved   konstruktion   af   cellefabrikker   er   overfladeudtrykkelse   af  
proteiner  gennem  anvendelse  af  det  cellulære  maskineri  en  attraktiv  
teknologi.  Denne   afhandling   inkluderer   en   rapport   om  udviklingen  
af   en   ny   platform   for   overfladeudtrykkelse,   der   bruger   grønt  
fluorescerende   protein   og   nanobodies   for   simpel   påvisning   og  
kvantificering  af  overfladepræsenteret  protein.  
  
De  to  forskningsprojekter  der  præsenteres  i  denne  afhandling  udgør  
eksempler  på  synbios  to  søjler,  men  viser  også  hvordan  hver  synbio  
venture   indeholder   aspekter   af   grundlæggende   såvel   som   anvendt  
forskning,  og  at  synbio  opstår  i  overlappet  mellem  de  to.  
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Prokaryotes   are   according   to   some   calculations   the   most   abundant  
biomass   on   Earth   [1].   Microbes   are   able   to   survive   in   extremely  
acidic,  hot,  wet,  and  dry  environments  –  in  fact,  they  survive  even  in  
space  [2,  3].  Additionally,  there  are  at  least  as  many  bacterial  cells  as  
human  in  our  bodies  [4,  5].  What  conclusion  can  we  draw  from  these  
facts?  Firstly,  that  humans  are  less  independent  than  we  like  to  think,  
incapable   of   surviving   without   microbes.   Secondly,   that   amazing  
abilities  exist  among  the  microscopic  creatures  of  the  world,  and  that  
this  harbours  a  huge  potential  also  for  us,  if  we  learn  from  it.    
  
Using  the  capabilities  already  developed  by  the  microbial  life  around  
us   and   applying   them  when   faced  with  new   challenges   is   not  new.  
People   have   used   microbes   for   production   of   bread   and   beer   for  
thousands  of  years   [6].  Using  cellular  machineries   to  produce  drugs  
is   a  major  practice   in   the  pharmaceutical   industry.   It   is   thus  a  well-­‐‑
established   method   for   humanity   to   turn   to   microbes   when   faced  
with  a  problem  in  our  human  world.  
  
One   of   the   largest   issues   ever   faced   by   mankind,   highlighted   by  
several  United  Nations   reports  and   latest   in   the  Sustainability  goals  
agreed  upon  by  the  General  Assembly  in  September  2015,   is  climate  
change   and   the   unsustainable  way   of   living   that   our   societies   have  
grown  accustomed  to   [7].  Animal  species  are  disappearing   from  the  
face  of  the  Earth  at  a  rate  estimated  to  be  up  to  100  times  higher  than  
it  would  be  without  human   impact   [8].  Average   temperatures  have  
risen  by  0.8  degrees  over   the   last  130  years  and  are  projected  to  rise  
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another   1-­‐‑3   degrees   by   year   2100,   depending   on   which   efforts   are  
undertaken  to  halt  negative  human  influence  [9].  In  a  2015  report,  the  
World  Wide   Fund   for  Nature   (WWF)   describes   the   terrible   state   of  
Earth’s  oceans,  with   examples   such  as   record-­‐‑high  acidification  due  
to  CO2  emissions,  declines  by  49%  in  marine  vertebrate  species  since  
1970,  and  even  more  dramatic  declines  in  fish  species  [10].  World  oil  
consumption   rose   by   65%   between   1973   and   2013,   to   3.7   billion  
tonnes  of  oil  equivalent  per  year  [11].  In  Scandinavia,  meat  continues  
to   be   a   major   food   source,   and   Swedes   have   increased   their   meat  
intake   by   40%   since   1990,   in   spite   of   a   reduced  meat   consumption  
being  one  of  the  United  Nation’s  main  recommendations  for  assisting  
in  reaching  the  sustainability  goals  [12,  13].    
  
Faced  with   these   uncomfortable   facts,   humans   are   again   looking   to  
the   microbial   world   for   inspiration.   In   combination   with   the  
advanced   genetic   engineering   techniques   developed   over   the   last  
decades,  much  effort  is  put  into  moving  production  from  fossil  fuel-­‐‑
based  systems  to  microbial-­‐‑based  value  creation.  The  modern  level  of  
bacterial-­‐‑based  production  is  part  of  the  new  and  promising  field  of  
synthetic  biology.    
  
Thesis  structure  
In   the   first   chapter   of   this   thesis,   I   outline   the   concept   of   synthetic  
biology   and   explain   how   it   is   used   to   increase   knowledge   of  
fundamental   mechanisms,   as   well   as   how   it   is   using   acquired  
knowledge  to  rebuild  existing  biological  systems.    
  
Next,  with  Escherichia  coli  as  model  system,  the  relevance  of  evolution  
for   synthetic   biology   is   discussed.   In   the   second   chapter,   I   describe  
the   theory   of   evolution   and   the   discussion   about   how   randomness,  
selection   and   adaptation   interact.   A   detailed   understanding   of   this  
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aspect   of   life   is   a   crucial   part   in   the   successful   synthetic   creation   of  
new  or  improved  organisms.  
  
In  the  third  chapter,  I  outline  how  synthetic  biology  can  use  obtained  
knowledge   of   biological   systems   to   develop   very   specific  
technologies,   in   this   case   particularly   microbial   surface   display.   I  
introduce   the   biotechnological   method   of   surface   display,   describe  
the   main   microbial   machineries,   and   exemplify   how   they   can   be  
applied  for  presenting  a  protein  of  choice  on  the  cell  surface.    
  
The   fourth   chapter   discusses   the   crossing   points   between   the   two  
main  themes  of  the  thesis,  and  their  future  perspectives.    
  
Hereafter  follows  a  paper  with  the  findings  of  a  study  on  how  ageing  
bacteria   adapt   to   their   environment.   It   describes   the   highly   non-­‐‑
random  mutational  patterns  that  appear  under  these  circumstances.    
  
The   last   chapter   contains   a   paper  where   a   new  E.   coli   platform   for  
surface   display   and   detection   is   depicted.   This   article   shows   how  
molecules   found   in   nature   can   be   combined   in   a   synthetic   biology  
approach  to  develop  new  useful  bioengineering  tools.    
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Chapter  1  





Traditional   biotechnology   uses   methods   like   cross   breeding   and  
selection  of  individuals  with  desired  traits,  and  is  still  used  today  in  
food-­‐‑producing   biotech   companies   since   anything   associated   with  
GMO  (genetically  modified  organisms)  is  fiercely  rejected  by  many  of  
the  EU  member  states  [14].  Genetic  engineering  became  possible  with  
the  development  of  PCR  (polymerase  chain  reaction)  and  restriction  
cloning   techniques   in   the   1970s   and   80s,   and   started   a   new   era   in  
biotechnology,  which  has   seen  an   impressive  advancement  of  DNA  
editing,  sequencing  and  synthesis  technologies  over  the  last  decades.  
The   concept   of   synthetic   biology   became   a   buzzword   in   the   early  
2000s,   introducing   a   new  way   of   thinking   about   biotechnology   and  
molecular  biology.  
  
1.1  Synthetic  biology  and  its  two  pillars  
Synthetic   biology   has   over   the   last   decade   emerged   as   one   of   the  
really  big  trends  within  scientific  research,  and  it  has  attracted  huge  
amounts   in   investments   for   both   academic   and   entrepreneurial  
activities   [15].   In   spite   of   its   status   as   a   topic   of   broad   and   intense  
interest,  the  definition  of  synthetic  biology  is  somewhat  loose.  
  
1.1.1  What  is  synthetic  biology?  
The  term  synthetic  biology  was  in  1974  used  by  Waclaw  Szybalski  to  
describe   the   “synthetic   phase”   of   biology   that   he   foresaw   to   be   the  
future   [16].   The   concept   of   synthetic   biology   (often   abbreviated  
	   5	  
synbio)   has   evolved   since   then   and   is   today   defined   somewhat  
differently  by  different  people.  Some  say  it  is  exclusively  the  building  
of  formerly  non-­‐‑existing  life  forms,  and  define  the  steps  prior  to  that,  
involving   understanding   the   natural   biology   better,   as   systems  
biology   [17].   Others,   however,   bring   together   the   understanding   of  
how  a  living  system  is  built  and  the  eventual  re-­‐‑building  of  it  in  their  
definition  of  synthetic  biology  [18].  This  view  is  inspired  by  physicist  
Richard   Feynman’s   famous   quote:   “What   I   cannot   create,   I   do   not  
understand.”   According   to   Drew   Endy,   who   was   instrumental   in  
establishing   the   term’s   usage  when   he   used   it   for   the   International  
Genetically   Engineered   Machine   (iGem)   competition,   synthetic  
biology   is   a  method,   an   approach   to  making   new   applications   that  
builds   on   genetic   engineering   but   adds   automated   DNA   synthesis,  
standards  and  abstraction  to  the  process  [19].  While  some  are  clearly  
separating   the   engineering   field   of   synbio   from   the   basic  
understanding  that  is  systems  biology  research,  others  emphasize  the  
understanding   of   how   a   system   works   as   a   fundamental   part   of  
synthetic  biology.    
  
1.1.2  Synbio  accomplishments  and  perspectives  
The   last   decade   has   seen   an   explosion   in   synthetic   biology-­‐‑based  
inventions  and  technologies,  resulting  in  a  whole  new  community  of  
academic   researchers,   entrepreneurial   start-­‐‑ups,   and   do-­‐‑it-­‐‑yourself  
biologists.   Start-­‐‑ups   have   emerged   in   large   numbers   from  
particularly  California  and  the  UK,  with  new  entrepreneurs  aiming  at  
applying   synthetic   biology   for   a   great   variety   of   purposes.   Ginkgo  
Bioworks  makes  designer  roses,  while  Caribou  biosciences  does  gene  
editing   and   Bento   bioworks   creates   3   kg-­‐‑heavy   do-­‐‑it-­‐‑yourself  
laboratories.   Amyris   and   Sanofi   have   received   much   attention   for  
their   yeast-­‐‑produced   anti-­‐‑malarial   drug   Artemisinin,   and   Oxitec   is  
the  object  of  much  attention  due  to  their  genetically  modified  insects,  
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prospected   to   be   released   in   nature   to   eradicate   disease-­‐‑carrying  
mosquito   species   [20].   In   Denmark,   microbe-­‐‑based   production  
systems   have   long   had   a   steady   base  with   insulin-­‐‑producing  Novo  
Nordisk,   enzyme-­‐‑making   Novozymes,   and   food-­‐‑focused   Chr.  
Hansen.   Academic   research   has   set   the   stage   for   the   explosion   of  
entrepreneurial   successes,   and   includes   genetic   tools   development,  
metabolic   engineering   advances,   and   natural   products  
manufacturing   [21].   DNA   synthesis   and   sequencing   have   seen  
increased  speed  and  reduced  costs,  and  genome  editing  has  reached  
entirely   new   levels   with   the   development   of   MAGE   (Multiplex  
Automated  Genomic  Engineering)  and  CRISPR  (Clustered  Regularly  
Interspaced  Palindromic  Repeats)  techniques.  Additionally,  synbio  is  
testing   new   ground   when   it   comes   to   knowledge   sharing.   In   an  
industry  traditionally  based  on  exclusive  rights  and  patenting,  parts  
of   the   synbio   community   are   advocating   a   new   open   biology   and  
sharing  strategy  that  challenges  old  structures,  much  in  resemblance  
with  the  open  source  development  within  computer  science  [22].  
  
1.1.3   Synthetic   biology   from   two   perspectives:   evolution   and  
engineering  
Within   the  concept  of   synthetic  biology  exists  an   interesting  conflict  
of  principles  (Figure  1).  From  a  biological  perspective,  the  process  of  
evolution   as   a   means   for   new   functions   and   forms   to   emerge  
constitutes   the   basis   of   life.   From   an   engineering   perspective,  
however,  this  sort  of  behaviour  of  a  system  is  inherently  problematic  
and  such  appearances  should  rather  be  controlled  and  designed  [23].    
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Figure   1.   The   synbio   conflict.   Biology   and   engineering   have   principally  
different  views  on  evolution.    
  
At  the  same  time,  synthetic  biology  has  been  stated  to  be  “extremely  
primitive   due   partly   to   fundamental   inadequacies   in   our  
understanding   of   biological   circuit   design”   (Michael   B.   Elowitz   in  
[17]),   and   design   of   evolutionarily   robust   biological   circuits   was  
pointed   out   as   a   synbio   safe   point   in   a   priority   report   presented   in  
2009   [24].  As   an   extreme   standpoint,   for   biological   systems   to   fully  
fulfil   engineering   requirements,   the   only   evolution   taking   place  
should   be   programmed   according   to   Smolke   and   Silver   [25].   This  
conflict   highlights   the   existence   and   importance   of   two   sides   of  
synthetic   biology;   the   need   for   understanding   fundamental  
mechanisms   of   biology   in   order   to   engineer   life,   and   the   increased  
understanding   of   fundamental   mechanisms   that   comes   from  
engineering   the   same   system.   The   two   are   intimately   linked,   with  
tools   developed   for   synbio   being   applied   for   fundamental   research,  
and   fundamental   research   continuously   feeding   in   to   synbio.  
Exemplified   by   the   case   of   evolution,   this   could   mean   exploiting  
evolutionary  processes  in  synbio  constructions.    
  
What  can  be  extracted  from  the  existing  variety  of  synbio  definitions  
is   that   synthetic   biology   requires   understanding   of   life   to   a   level  
where   we   can   rationally   design   and   build   it   de   novo.   Whether  







should be controlled 
Engineering=
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cycles   of   building,   and   studying   and   learning   from   the   results  
thereof,  is  essential.    
  
In   this   thesis,   two   complementary   paths   of   synthetic   biology   are  
explored:   evolution   is   studied   to   understand   mechanisms   that   can  
then   be   applied   for   rational   design,   and   engineering   using   known  
mechanisms   is   performed,   creating   tools   that   help   deepen  
understanding   of   said   mechanisms   as   well   as   improving   cell  
factories.    
  
1.2  Cell  factories  
The   concept   of   cell   factories   is   central   to   most   synthetic   biology  
applications  and  technologies  (the  famous  exception  being  an  in  vitro  
system   incorporating   full  gene   circuits  on  a  piece  of  paper   [26]).  As  
the   name   implies,   a   cell   factory   is   using   the  machinery   of   a   cell   to  
produce  a  compound  of  interest,  e.g.  a  protein,  a  medicinal  molecule,  
or   a   food   ingredient.  While   yeast   cell   factories   have   been   used   for  
centuries   for   production   of   alcohol   and   bread,   the   development  
started  taking  big  leaps  forward  in  the  1980s,  with  the  introduction  of  
advanced  genetic  engineering  techniques.    
  
1.2.1  Principle  and  principal  benefits  of  cell  factories  
Today,  oil  is  the  raw  material  behind  almost  everything  we  use  in  our  
everyday  lives:  the  paint  on  our  walls,  the  plastic  in  the  containers  we  
use,  the  fabric  of  our  clothes,  and  even  most  of  the  vanilla  taste  in  our  
cakes   [27].  One  of   the  major  benefits  of   cell-­‐‑based  production   is   the  
opportunity  to  make  molecules  we  need  without  petroleum,  thereby  
reducing  carbon  dioxide  emissions  and  environmental  damage.  Cell  
factories,   in   contrast   to   common   industries,   use   sugar   in   various  
forms   as   raw   material.   Through   metabolic   rewiring   or   boosting   of  
enzymatic   pathways,   cells   can   be   tuned   into   producing   a   great  
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variety  of  products,  and  in  the  best  cases  use  renewable  resources  in  
efficient  ways  (Figure  2).    
  
Figure  2.  The  principle  of  a  cell  factory.  Cheap,  naturally  occurring  sugars  
(carbon   source)   are   fed   to  microorganisms,  whose  metabolic   networks   are  
wired  to  allow  production  of  valuable  compounds  such  as  drugs,  nutritional  
molecules,  or  fuels  (product).  
  
1.2.2  Organisms  and  products    
Many   different   organisms   have   been   explored   as   cell   factories.   The  
main   workhorses   in   synthetic   biology   are   Escherichia   coli   and  
Saccharomyces   cerevisiae,   but   also   mammalian   cells   for   particularly  
pharmaceutical   proteins   [28].   Many   alternative   organisms   are  
continuously   being   explored,   and   moss,   algae,   insect   cells   and  
anaerobic   bacteria   are   a   few   of   the   more   exotic   ones.   Eukaryotic  
organisms   are   preferably   used   for   production   of   proteins   requiring  
post-­‐‑translational  modifications  [29],  but  oftentimes  bacteria  are  used  
due  to  their  simplicity  of  modification,  low  cost  and  fast  growth  [30].  
While  it  is  proven  time  and  time  again  that  it  is  possible  to  make  all  
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sorts  of   complex  molecules   in  microbes,   in  many  cases  making   it   at  
high   enough   titers   at   low   enough   prices   remains   an   issue.   Fully  
realising   the   potential   of   synthetic   biology   and   cell   factories   will  
require  collaboration  between  disciplines,  academia  and  industry,  as  
well  as  deepened  understanding  of  cellular  mechanisms  [17,  31].    
  
1.3  The  model  organism  
E.   coli   is   often   referred   to   as   the  most  well   characterised   species   on  
Earth.  It  has  been  used  by  humans  for  a  century  and  provided  clues  
to  many  of  our  questions  about   life   and  our  own  bodies’  molecular  
details   [32].   Some   strains   of   E.   coli   are   pathogenic,   whereas   others  
exist  in  the  normal  human  and  animal  gut  flora.  Its  benefits  as  a  host  
for  synthetic  biology-­‐‑based  engineering  and  production  include  a  fast  
doubling   time,  with   cells   dividing   every   20  minutes   under   optimal  
conditions,   easiness   to   grow   to   high   densities,   and   a   vast   array   of  
available  methodologies  for  its  genetic  manipulation  [33,  34].    
  
While   E.   coli  may   in   everyday   life   be   mostly   associated   with   gut  
infections,  E.  coli   is   really  a   saviour   rather   than  a   foe.  As  one  of   the  
most   important  model  organisms   there  are,  E.  coli  has   taught  us   the  
basics   of   bacterial   conjugation   [35],   gene   regulation   [36]   and   gene  
structure  [37].  Research  in  E.  coli  has  laid  the  foundation  for  much  of  
modern  biotechnology,  with  it  being  essential  in  the  development  of  
recombinant   DNA   technologies   [38].   The   use   of   E.   coli   for  
recombinant  protein  production  is  widespread,  and  that  for  purposes  
such   as   pharmaceuticals,   biofuels   and   amino   acids   manufacturing  
[39].   A   famous   example   is   the   production   of   insulin   that   was  
accomplished  in   the  1980s  [40].  Today,  E.  coli  continues   to  be  one  of  
the  most  used  organisms  within  biotechnology  and  synthetic  biology.  
Drawbacks  of  using  E.  coli  include  the  afore-­‐‑mentioned  incapacity  to  
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produce   post-­‐‑translational   modifications,   and   production   of  
endotoxins  [30].  
1.3.1  Different  strains  
Although  E.  coli  is  one  species,  there  are  many,  very  different,  strains.  
The   two  major   laboratory   strains   are   the   so-­‐‑called   B   and  K   strains.  
Both   strains   have   the   typical   circular   E.   coli   chromosome  
encompassing  4.6  million  basepairs  coding  for  around  4500  proteins.    
  
The   work   in   this   thesis   was   performed   using   the   K   strain   K12  
MG1655   and   the   B   strain   BL21,   for   the   study   of   evolution   and  
mutation  mechanisms  as  described  in  Chapter  2  and  Paper  I,  and  for  
the  purpose  of  surface  protein  production  as  described  in  Chapter  3  
and  Paper  II,  respectively.    
  
K12  MG1655  was  the  first  E.  coli  strain,  and  one  of  the  first  genomes  
ever,  to  be  fully  sequenced  [41],  whereas  BL21  was  sequenced  in  2009  
[42].   Comparison   of   their   genomes   revealed   differences   mainly   in  
their   membrane   constitution:   BL21   cannot   form   capsule  
polysaccharides   and   also   lacks   fully   functional   lipopolysaccharide  
(LPS),   due   to   a   truncation   in   the   core   oligosaccharide   [42].      Both  
strains   are   routinely   used   in   laboratory   work,   with   BL21   being  
especially   suitable   for   protein   production,   partly   due   to   its   lack   of  
certain  proteases  [34].    
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Chapter  2  





Evolution  –   this  beautifully  simple  yet   refined  basis   for   life   the  way  
we  know   it.  While   the  basic  principle   seems   so   easy   to  grasp,   there  
are   layers   of   evolution   that   are   far   more   intricate.   Do   subtypes   of  
evolutionary  mechanisms   exist   and   can   they   be   turned   on   and   off?  
Can  cells  sense  environmental  cues  and  use   them  to  steer   their  own  
evolution?   These   questions  might   sound   bold,   but   one   could   argue  
that   it  would  be  even  bolder   if   life  did  not  develop  high  degrees  of  
control   of   the   most   important   process   of   all,   and   recent   research  
indeed  reveals  that  such  mechanisms  exist.    
  
2.1  The  basic  principles  of  evolution  
We  may  think  that  we  all  know  and  agree  on  what  evolution  is  and  
how   it   works,   but   when   it   comes   to   discussing   the   details   of   it,   it  
turns   out   there   are   many   controversial   discussion   points.   The   130-­‐‑
year-­‐‑old   concept   of   evolution   as   described   by   Darwin   has   been  
challenged   by   many   differing   ideas   with   regards   to   the   ever-­‐‑
fascinating  question  of  heredity  and  development  of  life.    
  
2.1.1  Instructed  evolution  
In   1809,   the   French   biologist   Jean-­‐‑Baptiste   Lamarck  was   the   first   to  
present  an  idea  of  evolution  of  life;  he  suggested  that  life  on  Earth  did  
not  appear  there  exactly  the  way  it  presently   looked,  but  that   it  had  
developed  over   time   [43].  Lamarck’s   idea,  not  at  all   controversial  at  
the  time,  was  that  organs  that  were  much  used  by  an  animal  would  
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grow   bigger,   whereas   organs   that   were   not   used   would   become  
smaller.  These  advantageous  changes  would  take  place  in  individual  
animals   during   their   lifetime,   and   be   transferred   to   their   offspring.  
Life,  he  argued,  is  always  developing  towards  increasing  complexity.  
Although   Lamarck   was   a   pioneer   who   suggested   that   life   was   not  
fixed  but  changed  depending  on  its  environment,  something  that  was  
heavily   criticised  by   religious   representatives,  he   is   remembered   for  
the  later  ridiculed  theory  that  the  environment  instructs  evolutionary  
changes.   Interestingly,   the   Lamarckian   evolution-­‐‑thought   that  
acquired   characteristics   can   be   transferred   to   the   next   generation   is  
today   gaining   new   relevance.   In   CRISPR   research   as  well   as   in   the  
fields   of   epigenetics   and   that   of   evolution   of   life,   where   IAC  
(Inheritance  of  Acquired  Characteristics)  is  the  term  used  to  describe  
Lamarckian-­‐‑style   evolution   events,   the   topic   is   attracting   renewed  
interest.   A   discussion   of   some   of   these   cases   is   placed   in   the   last  
section  of  this  chapter.    
  
2.1.2  Natural  selection  
In   the  mid   1800s,   Charles   Darwin’s  model   of   evolution,  which   still  
holds  today,  was  presented  [44].  Building  on  among  others  the  work  
of  Lamarck,  both  Darwin  and  Alfred  Russel  Wallace,  independently,  
developed  theories  of  evolution  based  on  what  Darwin  called  natural  
selection.   Inspired   by   the   field   of   economics,   where   the   pressure   of  
population   growth   on   a   state’s   capacity   to  withhold  welfare   for   all  
had  been  pointed  out,  Wallace  and  Darwin  concluded  that  the  same  
must  be  true  for  the  animal  kingdom.  Due  to  limited  food  or  space,  a  
population   could   not   grow   freely   and   continue   to   expand  
indefinitely.  If  an  individual  had  traits  that  were  beneficial  under  the  
circumstances  it  was  living  in,  it  would  have  an  increased  likelihood  
of   surviving   and   propagating.  With   each   generation,   the   beneficial  
trait  would   become  more  widespread   in   the   population,   and   in   the  
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long  run  entirely  new  functions  could  develop  [44].  Natural  selection  
was   thus   defined   as   the   principle   that   individuals   with   beneficial  
traits,  or  in  other  words  with  the  highest  fitness,  would  have  the  best  
chance   of   being   preserved,   and   that   they   would   pass   on   their  
characteristics  to  their  offspring.  
  
At   first,   natural   selection   was   argued   for   with   observational   data  
based  on  bird  species  studies,  and  the  Lamarckian  theory  which  had  
its   base   in   “folk   wisdom”   did   not   disappear   easily   [45].   With   the  
discoveries   of   genes   and   mutation   in   the   19th   century,   however,  
Darwin’s   theory   became   the   dogma.   When   the   details   of   genetic  
inheritance  were  revealed  in  the  early  1900s,  this  new  knowledge  was  
combined  with  Darwin’s  ideas  of  evolution  through  natural  selection  
into   what   is   commonly   referred   to   as   neo-­‐‑Darwinism   or   modern  
synthesis:   evolution   of   a   species   due   to   natural   selection   of  
advantageous,   randomly   generated   mutations   from   a   genetically  
diverse   population.   The   Luria-­‐‑Delbrück   fluctuation   experiment,  
reported   on   in   1943,  was   instrumental   in   its   demonstration   of   how  
mutations   in   E.   coli   occurred   before   exposure   to   a   specific  
environmental   pressure,   and   hence   were   not   due   to   instructed  
adaptation   [46].   A   third   component   of   evolutionary   theory   is   the  
concept   of   genetic   drift   that   was   first   described   by   Sewall   Wright;  
randomly  generated  mutations’   random  persistence   in   a  population  
(Figure  3)  [45,  47].    
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Figure   3.   Schematic   overview   of   evolutionary   concepts.   In   Lamarckian  
theory,  environmental  factors  direct  specific,  beneficial  mutations  that  allow  
an   organism   to   adapt.   The   Darwinian   principle   is   that   of   randomly  
generated   mutations   enabling   selection   of   beneficial   mutations   when   an  
organism   is   subjected   to   a   selection   pressure   caused   by   environmental  
factors.   The  Wrightean  module   of   evolution   concerns   randomly   generated  
mutations  that  are  fixed  in  an  organism  through  random  processes.  Adapted  
from  [48].  
  
2.1.3  Terms  and  definitions  related  to  evolution  mechanisms  


















and  that  it  does  so  via  natural  selection,  discussion  was  sparked  anew  
on   the  mechanistic   details   of   evolution,   and   the  model   organism  E.  
coli  once  again  became  the  focus  of  attention.  A  particularly  debated  
topic   is   that  of  adaptive  evolution,   i.e.   the  way  mutations  appear   in  
microorganisms   adapting   to   a   new   environment.   The   discussions  
taking   place   revolve   around   numerous   critical   terms   presented   in  
Table  1.    
  
Table  1.  Overview  of  commonly  used  terms  in  the  discussion  of  evolution  
and  adaptation.  Partly  adapted  from  [49]  and  [50].    
Term   Definition  
Directed  mutagenesis   Under  selection,  only  mutations  that  relieve  the  
selection   pressure   appear   (no   unselected  
mutations).    
Adaptive  mutagenesis   Under   selection,   mutations   that   relieve   the  
selection   pressure   appear,   with   or   without  
additional,  unselected  mutations.    
Stress-­‐‑induced  
mutagenesis  
A  general  mutagenic  state   induced  in  response  
to  stress.  
Transient  mutagenesis   A   state   of   temporarily   increased  mutation   rate  
affecting  the  whole  genome.  
SOS  response   DNA-­‐‑damage   stress   response   that   upregulates  
ca.  40  genes  involved  in  DNA  repair  and  DNA  
damage  tolerance.  
RpoS  response   Large   general   stress   response   driven   by   the  
transcriptional   activator   RpoS,   upregulating  
transcription  of  ca.  340  genes.  
Hypermutagenesis   A   state   of   extremely   high   mutation   rate  
accumulating   mutations   across   the   whole  
genome.  
Stationary  phase   The   stage   of   a   laboratory   batch   culture   when  
one   or   more   nutrients   are   finished.  
Accumulation  of  waste  due  to  cell  metabolism.    
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Quiescent  state   Non-­‐‑dividing,   dormant   state   of   a   cell  where   it  
does  not  replicate.  
Starvation   Lack   of   one   or   more   nutrients   required   for  
growth.  
Adaptive  evolution   Evolution   through   selection   for   improved  
fitness.    
  
2.2  The  controversy  of  adaptive  mutation  
It   is   remarkable   how   much   controversy   the   studies   of   cells’  
adaptation   to   their   environment   have   ignited   in   the   scientific  
community.   Two   distinct   camps   exist,   and   have   been   fiercely  
counter-­‐‑arguing   each   other   for  many   years.   One   side   determinedly  
states  that  all  observations  on  adaptation  can  be  explained  by  classic,  
neo-­‐‑Darwinian   selection   of   pre-­‐‑formed   mutations   and   growth  
advantage.  Other   researchers   interpret   the   same   scientific   results   as  
evidence   for   stress-­‐‑induced   mutagenesis   restricted   in   time   and  
genomic  space  via  a  multitude  of  molecular  mechanisms.  The  heat  of  
the  debate  can  be  sensed  via  expressions  such  as  “we   feel   that   there  
can   be   no   real   controversy”   appearing   in   scientific   articles   on   the  
topic  [50].  What,  then,  is  the  controversy  about?  
  
2.2.1  The  lac  system  
In   two   papers   published   in   1988   and   1991,   John   Cairns   and  
colleagues,   particularly   Patricia   Foster,   reported   experiments   that  
have   since   formed   the  basis   for   a   large  number  of   studies  meant   to  
decipher   how   bacterial   cells   adapt   to   their   environment   [51,   52].  E.  
coli   cells  with   a   chromosomal  deletion   of   the   lac  operon,   containing  
the  genes  for  lactose  fermentation,  were  plated  on  lactose-­‐‑containing  
medium.  The  cells  harboured  an  F’  conjugative  plasmid  with  the  lacI-­‐‑
lacZ   genes   disrupted   by   a   leaky   +1   frameshift   mutation,   causing  
reduction  of  LacZ  activity  to  2%  of  that  of  revertants  [53].  While  the  
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cells   did   not   form   any   colonies   immediately   after   being   plated   on  
lactose,   colonies   started   to   appear   after   two  days   of   incubation   and  
continued   to   form   over   the   following   eight   days.   The   papers  
concluded   that   the   bacteria   were   sensing   and   adapting   to   their  
environment,   and   that   “cells   may   have   mechanisms   for   choosing  
which  mutations  will  occur”  [51].      
  
After   the   original   experiments   by  Cairns   and   Foster,   the   lac   system  
was   extensively   explored   as   many   researchers   repeated   the  
experiment   or   set   up   similar   tests,   but   without   the   scientific  
community   ever   reaching   a   conclusion   satisfactory   to   everyone.  
Designing  a  robust  system  for  studying  these  types  of  mechanisms  is  
evidently   very   complicated.   In   this   long-­‐‑lasting   debate,   with   the  
latest   review   coming   out   last   year   [54],   the   controversy   has  mostly  
been   about   the   interpretation   of   the   scientific   results,   rather   than  
about   the   results   as   such.   Adaptation,   defined   as   “the   process   by  
which   new  mutations   arise   under   selective   conditions   regardless   of  
the  mechanism”   [55,  56],   is   taking  place,   the  question   is   just  how?  A  
number   of   different   models   for   explaining   the   observations   have  
been   put   forward   and   are   presented   next.   The   first   two   propose  
stress-­‐‑induced   mutagenesis   to   account   for   the   adaptive   mutations,  
whereas  the  latter  two  refer  to  growth  and  selection.  
  
The  directed  evolution  model  
One  model  states   that  mutation   is  directed;  under  stress,   there   is  an  
increase  in  overall  mutation  rate  in  all  cells  and  based  on  sensed  cues  
from  the  stressing  environment,  mutations  are  specifically  directed  to  
genes  that  would  be  beneficial  to  mutate.  This  was  the  original  line  of  
thinking   in   the   very   first   lac-­‐‑system   studies   but   has   not   received  
much  support  [51,  52,  57].    
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The  hyper-­‐‑mutable  subpopulation  model  
A   second  model   suggests   that   a   small   subpopulation   of   the   plated  
cells  become  hypermutators  in  response  to  stress  [58].  Beneficial  traits  
are  then  selected  from  this  subpopulation.  Evidence  in  support  of  this  
model   include   a   generally   higher   mutation   frequency   in   lac+   cells  
[59–61]   whereas   the   counterarguments   are   that   the   mutation   rate  
required   to   obtain   that   many   mutations   would   be   unrealistically  
elevated  [62].    
  
The  amplification  model  
This   model   refutes   stress-­‐‑induced   mutagenesis   and   explains   the  
Cairns-­‐‑Foster  experimental  results  by  local  amplification  of  the  leaky  
lac   allele   [54,   56].   Continuous   amplification   in   this   model   leads   to  
firstly  a  growth  advantage,  and  secondly  an  increased  probability  of  
mutagenesis   simply   due   to   the   sheer   number   of   lac   alleles   being  
higher.   Foster,   on   the   other   hand,   argues   that   if   the   amplification  
model   were   true,   the   increase   in   mutants   should   be   exponential  
rather  than  show  the  observed  linearity  [49].    
  
A  compromise  model?  
As   late   as   last   year,   Maisnier-­‐‑Patin   and   Roth   discussed   the  
controversy   again,   and   proposed   a   new   model   that   combines  
characteristics   of   the   previously   suggested   ones   [54].   They   propose  
that  prior   to  selection,   the  F’  plasmid  copy  number  has   increased   in  
some   cells,   via   unknown   mechanisms.   In   the   plated,   non-­‐‑growing  
cells,   energy   from   the   leaky   lac   allele   is   then   used   to   replicate   the  
plasmid,  and  each  such  event   is  a  chance   for   the  mutant   lac  gene   to  
revert.   At   the   same   time,   both   the   SOS   response   and   the   RpoS  
response   are   activated.   The   error-­‐‑prone   DNA   polymerase   DinB  
encoded   on   the   plasmid   is   responsible   for   increasing   reversion   rate  
for   lac,   while   not   affecting   the   chromosomal   DNA   since   the  
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chromosome  is  not  replicating.  They  conclude  that  the  mutations  are  
directed  in  the  sense  that  only  the  plasmid  is   increasingly  replicated  
in  the  presence  of  increased  levels  of  DinB,  and  that  once  a  reversion  
takes   place,   all   non-­‐‑revertants   are   lost   due   to   selection,   leading   to  
direction   of   mutagenesis   to   those   nucleotides   that   limit   growth.   In  
essence,   they  are  arguing  how  selection  mimics  any  sort  of   induced  
mutagenesis,   and   that   the   dogma   that   mutation   and   selection   are  
independent  still  holds  true.    
  
While  some  researchers  have  been  discussing  this   topic   for  decades,  
it  is  noteworthy  that  others  strongly  criticise  the  whole  experimental  
set-­‐‑up   and   go   as   far   as   to   say   that   the  whole   Cairns-­‐‑Foster   system  
debate  is  a  result  of  “serious  hubris”  and  a  waste  of  time  as  well  as  a  
mistake   to   ever   be  published   [63].   It   is   indeed  not   very   bold   to   say  
that   the   lac   system   is   somewhat   flawed,   and   that   a   different  
experimental   set-­‐‑up   with   more   easily   interpreted   output   would   be  
beneficial  for  the  discussion.    
  
2.2.2  Transcription-­‐‑associated  mechanistic  models    
In   the   late   1980s   and   mid   1990s,   two   articles   reported   non-­‐‑
Lamarckian,   transcription-­‐‑related   hypotheses   for   adaptive  mutation  
[64,  65].  During  transcription,  in  the  transcriptional  bubble,  the  DNA  
strands  are  unusually  exposed,  increasing  the  risk  for  DNA  damage.  
This   is   true  particularly   for   the  non-­‐‑transcribed   strand,   to  which  no  
messenger  RNA  (mRNA)  molecule  is  base-­‐‑pairing.  Based  on  this  fact,  
Davis   suggested   that   during   transcription   in   non-­‐‑growing   cells,   the  
non-­‐‑transcribed  strand  is  prone  to  mutagenesis  and  that  this  could  be  
the   mechanism   behind   adaptive   mutation   [64].   Bridges   reported   a  
related   but   contrasting   model,   which   has   been   termed  
retromutagenesis  [65].    
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Retromutagenesis   is   the   principle   of   mutation   to   the   transcribed  
strand  during  transcription,  leading  to  a  beneficial  phenotype  change  
that  allows  growth  and  thereafter  DNA  replication  and  fixation  of  the  
mutation   also   on   the   non-­‐‑transcribed   (coding)   strand   and   in   the  
genome   (Figure   4).   Retromutagenesis   hence   allows   for   mutation   to  
genes   that   are   transcribed,   and   in   that   sense   has  parallels   to   the   lac  
amplification   model,   where   amplification   of   a   gene   allows   for   its  
increased  mutation.  The  unique  characteristic  of  retromutagenesis   is  
the   reversed   order   that   a  mutation   occurs   in;   that   a  modification   is  
fixed  in  the  DNA  first  after  expression  of  the  mutated  gene.  Recently,  
new   evidence   was   presented   in   support   of   the   retromutagenesis  
model:   mutagenized   DNA   was   fixed   by   compensating   mutation  
highly  dominantly  taking  place  on  the  transcribed  strand  [55].    
  
  
Figure   4.  The   retromutagenesis   principle   exemplified  with   two   common  
mutational  mechanisms.  (A)  Upper  panel:  Illustration  of  the  mechanism  of  
retromutagenesis   after   8-­‐‑oxoguanine   (encircled   G)   formation   on   the  
transcribed   strand   (ts,   dark   grey   line)   that   enables   insertion   of   an   adenine  
ribonucleotide   in   the   mRNA   (green   waved   line).   The	   mutated   mRNA  
enables   growth   and   a   round   of   replication   that   permanently   fixes   the  
mutation  on  the  coding  strand  (cs,   light  blue   line)   in  daughter  cells.  Lower  
panel:   8-­‐‑oxoguanine   formation   on   the   coding   strand   does   not   transfer   to  
daughter  cells.  (B)  Illustration  of  retromutagenesis  after  cytosine  nucleotide  
deamination  into  uracil   (encircled  U),  enabling  base  pairing  with  A.  Upper  
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and   lower   panels   show   result   of   cytosine   deamination   on   transcribed   and  
coding  strand  respectively,  as  detailed  in  (A).  Figure  from  Paper  I  [66].  
  
The   fact   that   the   adaptive   mutation   controversy   has   persisted   for  
almost  30  years  shows  with  no  room  for  doubt  that  the  Cairns  system  
is   imperfect   and   that   other   ways   of   studying   adaptation   would   be  
helpful.  One  lead  in  the  hunt  to  understand  how  organisms  adapt  to  
their  environment  might  be  provided  by  the  retromutagenesis  model,  
but  the  systems  where  it  has  been  tested  until  now  are  dependent  on  
mutagens.  To  complement   the  existing  results,  we  developed  a  new  
experimental  system  for  studying  adaptation  of  ageing  E.  coli  cells  to  
their  environment.  
  
2.3  The  adenylate  cyclase  –  CRP  experimental  system    
In  an  attempt  to  shed  more  light  on  the  process  of  adaptive  evolution,  
part   of   the   work   for   this   thesis   was   done   on   a   completely   new  
experimental   system,   designed   to   address   some   of   the   questions  
regarding  how  bacterial  cells  adapt  to  their  environment.  The  desire  
for  such  a  system  is  for  it  to  be  minimally  perturbed  compared  to  the  
wildtype,   in   order   to   have   any   general   implications,   while   at   the  
same  time  generate  enough  mutants  to  enable  their  study;  hence,  for  
it  to  have  a  weak  mutator  phenotype.    
  
2.3.1  Adenylate  cyclase  and  the  cAMP  receptor  protein  
One   of   the   main   regulators   in   E.   coli   is   the   cyaA-­‐‑encoded   kinase  
adenylate  cyclase.  This  enzyme  catalyses  the  conversion  of  ATP  into  
cyclic  AMP  (cAMP),  one  of  the  main  second  messenger  molecules  in  
E.   coli   [67].   Next,   cAMP   binds   to   the   cAMP-­‐‑receptor   protein   (CRP,  
also   known   as   Catabolite   activator   protein,   CAP)   and   causes   it   to  
change  conformation,  which  activates  it  as  a  transcriptional  regulator  
controlling  expression  of  more  than  100  genes  (Figure  5)  [68].    
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Figure   5.   Principle   of   cAMP-­‐‑CRP   transcriptional   regulation.   Adenylate  
cyclase   converts   ATP   into   cAMP,   which   upon   binding   to   CRP   causes   a  
conformational  change  in  CRP,   leading  to   its  activation  as  a  transcriptional  
regulator.    
  
2.3.2  Observation  of  cells’  adaptation  over  two  months    
Paper   I   of   this   thesis  describes   a   study  where  we   sequenced  almost  
100  genomes  of  cells  that  adapted  to  an  inaccessible  nutrient  over  the  
course  of  two  months.  The  experimental  system  is  based  on  the  E.  coli  
strain   K12   MG1655.   The   cyaA   gene   is   removed,   which   hinders  
formation   of   cAMP   and   consequently   formation   of   the   cAMP-­‐‑CRP  
complex.  Thus,   transcriptional   regulation  of   a  multitude  of   genes   is  
inhibited.  Furthermore,   the  strain  has  a  deletion  of   fnr,  which  codes  
for  a  CRP  homolog  [69].    
  
When  the  strain  is  plated,  from  early  stationary  phase  cultures,  onto  
plates   containing   lactose-­‐‑free   MacConkey   medium   supplemented  
with   maltose   as   the   only   available   carbon   source,   they   grow   into  
small,  white  colonies  but  not  beyond.  However,   if   the  plates  are   left  
in  the  incubator  for  some  days,  red  protrusions,  called  papillae,  start  
to   form.   These   are   cells   that   are   adapted   to   their   new   environment  
and   capable   of   metabolising   maltose.   This   situation   would   in  
principle   be   similar   to   a   starvation   situation   in   nature,   and   the  
cAMPATP
Adenylate cyclase CRP cAMP-CRP
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question  be:  which  are  the  mechanisms  behind  cells’  adaptation  to  a  
new,  hostile  environment?  These  adaptive  mutants  continue  to  form  
over  the  course  of  two  months.  The  goal  of  the  experiment  reported  
in  Paper  I  was  to  study  these  mutants  in  detail  to  a  level  that  has  not  
been   done   before,   by   sequencing   the   whole   genome   of   a   large  
number  of  the  papillae.  Another  unique  factor  of  this  experiment  was  
the  long  time  period  over  which  the  adapted  mutants  were  collected.  
Each   papilla   that   appeared   was   purified   and   characterised  
phenotypically,   and   a   representative   group   consisting   of   96   of   the  
mutants  was  sequenced.  In  addition,  Paper  I  contains  an  analysis  of  a  
larger   group   of   CRP   sequences   from   mutants.   A   summarising  
overview  of  the  observations  found  in  the  genome  sequencing  data  is  
found  in  Table  2.      
  
Table   2.   Overview   of   mutation   events   in   the   adaptive   mutation  
experiment  of  Paper  I.    
Number  of  genomes  sequenced   96  
Number  of  CRP  genes  sequenced   594  
Number  of  mutations  per  genome,  average   5  
Number  of  missense  mutations  per  genome,  average   2.5  
Range  of  number  of  mutations  per  genome    (missense)   1-­‐‑14    
(1-­‐‑7)  
Total  number  of  genes  with  missense  mutations   83  
Fraction  of  all  missense  mutations  consistent  with  8-­‐‑oxoG  
mechanism  (CRP)  
69%  (28%)  
Fraction   of   all   missense   mutations   consistent   with   C-­‐‑
deamination  mechanism  (CRP)  
28%  (66%)  
Fraction  of  8-­‐‑oxoG  mutations  on  transcribed  strand  (CRP)   84%  (98%)  




The   results   show   a   highly   non-­‐‑random   pattern   of   mutation,   with  
adaptive   mutation   taking   place   in   specific   hotspot   genes,   in   a  
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background   of   low   mutation   rate,   appearing   over   the   whole   time  
period  and  showing  a  strong  bias  for  the  transcribed  strand.  As  could  
be   expected,   the   major   hotspot   gene   is   crp.   Another   oftentimes-­‐‑
mutated   gene   is   that   of   the   transcriptional   activator   (sigma   factor)  
protein  RpoS,  controller  of  a  general  stress  response.    
  
The  strand  bias  is  one  of  the  most  striking  results  we  obtain  and  the  
basis   for  determining  on  which  strand  a  mutation   takes  place   is   the  
following:   Under   starvation   conditions   there   are   two   types   of  
mutations   that   are  widely   dominating   over   all   others,   and   they   are  
functioning   through   8-­‐‑oxoguanine   formation   and   cytosine  
deamination,  respectively  [70–72].  In  Paper  I,  all  mutations  consistent  
with   the   typical  8-­‐‑oxoG  or  C-­‐‑deamination  mechanisms  are  assumed  
to  be  caused  by   these  mechanisms,  and  the  strand   is  determined  by  
backtracking   the   mutation:   a   C-­‐‑to-­‐‑A   transversion   on   the   coding  
strand   is   consistent  with  8-­‐‑oxoguanine   formation  on   the   transcribed  
strand,  whereas  a  G-­‐‑to-­‐‑A  transition  on  the  coding  strand  corresponds  
to  a  cytosine  deamination  event  on  the  transcribed  strand  (Figure  6a-­‐‑
b).  By   analysing   the  genome  data  with   these  mutational   glasses   on,  
we   discovered   that,   unsurprisingly,   97%   of   all   missense   mutations  
were  formed  by  these  common  mutagenesis  mechanisms,  and  –  more  
surprisingly  –  that  84  and  93%  of  8-­‐‑oxoG  and  C-­‐‑deamination  events  
respectively   were   formed   on   the   transcribed   strand.   This   strongly  
indicates   that   adaptive   mutations   are   formed   in   a   transcription-­‐‑
associated  manner  and  supports  the  retromutagenesis  model.    
  
8-­‐‑oxoG   mutagenesis   leads   to   transversion   mutations   (changes  
between  purine  and  pyrimidine  bases),   in  contrast   to   the   transitions  
(purine  to  purine  or  pyrimidine  to  pyrimidine  changes)  caused  by  C-­‐‑
deamination   (Figure   6c).   Transition  mutations   are   twice   as   likely   to  
happen   as   transversions,   and   can   be   caused   by   tautomerisation  
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during  replication  [73].  Distinctive  from  this,  we  observe  transversion  
mutations   to   be   dominating,   and   in   addition   this   domination   is  
increasing   with   time   over   the   2-­‐‑month   experimental   course.   This  
suggests   that   the   oxidative   environment   becomes   increasingly  
influential  over  time.  Interestingly,  the  increase  in  8-­‐‑oxoG  mutations  
is  paralleled  by  an   increase   in  RpoS  mutations,   something   that  may  
suggest  that  RpoS  counteracts  8-­‐‑oxoG  formation.  In  consistence  with  
this   hypothesis,   starved   Pseudomonas   Putida   cells   deficient   in   RpoS  
show  significantly  increased  mutation  rate  [74].  
  
Figure   6.   Illustration  of  mutation  principles.   (A)  Observation   of   a  C-­‐‑to-­‐‑A  
transversion  on  the  coding  strand  (cs)  corresponds  to  a  G  being  oxidised  on  
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strand  corresponds  to  deamination  of  C  to  U  on  the  transcribed  strand.  (C)  
Transitions  are  changes  between  one-­‐‑ring  pyrimidines  or  two-­‐‑ring  purines,  
whereas   transversions   are   conversions   from   pyrimidine   to   purine   or   vice  
versa.    
  
Interestingly,  several  of  the  hotspot  genes  identified  in  our  study  are  
subject   to   autoregulation,  meaning   that   when   their   levels   decrease,  
their  transcription  is  triggered  [75,  76].  In  a  2015  study,  Franchini  et  al  
reported   unaffected   transcriptional   levels   of   crp   in   a   cyaA   deletion  
strain   grown  under   glucose   limited   conditions   [77].   192   genes  were  
differentially   expressed   in   the   cyaA   deletion   strain,   152   of   those  
down-­‐‑regulated   as   an   effect   of   the   absence   of   cAMP-­‐‑CRP.  
Hypothetically,  the  lack  of  effect  on  crp  expression  levels,  keeping  the  
gene  transcribed  under  difficult  conditions,  can  be  beneficial.    
  
In   our   experimental   set-­‐‑up,   the   process   is   undoubtedly   that   of  
selection,  but  not  of  randomly  generated  mutants.  Rather,  we  suggest  
that   adaptive   mutations   appear   in   regions   that   keep   being  
transcribed   as   cells   age   (for   instance,   autoregulated   genes),   via  
retromutagenesis  and  selection  of  beneficial  phenotypes,  which  then  
fix  mutations   in   the   genome   through   replication.  Autoregulation   of  
genes   is   a   potential   mechanism   to   ensure   that   adaptive   mutation  
takes  place  only  in  specific  genes  when  cells  starve  and  age.    
  
2.4  A  new  view  on  evolution  and  its  role  in  synthetic  
biology  
In   the   heat   of   discussing   evolutionary   principles   in   general,   and  
adaptive  evolution  in  particular,  might  it  be  time  to  update  our  views  
on  evolution  once  again?  Perhaps,  as  is  often  the  case,  the  true  picture  
lies  somewhere  in-­‐‑between  the  extremes.    
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2.4.1  A  continuum  of  evolutionary  mechanisms  
The   era   of   genomic   analysis   has   enabled   insight   into   the  molecular  
mechanisms   of   mutation   and   heredity   that   casts   new   light   on  
evolutionary  processes.  Interestingly,  the  hottest  scientific  topic  of  the  
last   years,   the   CRISPR-­‐‑Cas   system   of   bacteria,   has   again   brought  
attention  to  Lamarckian  mechanisms  of  evolution.    
  
CRISPR   (short   for   Clustered   Regularly   Interspaced   Palindromic  
Repeats)   together  with   the  Cas   (CRISPR-­‐‑associated)   nucleases   carry  
out  the  adaptive  immune  response  of  bacteria.  By  cutting  out  pieces  
of   invading  viruses’  DNA  and  saving   them  in  CRISPR  arrays   in   the  
bacterial  genome,  the  bacterium  can  on  a  later  occasion  recognise  the  
invader   and   guide   a  Cas   nuclease   to   its  DNA,  where  Cas   creates   a  
double-­‐‑bond  break  [78].  There  is  a  clear  Lamarckian/IAC  tone  to  this  
environment-­‐‑instructed  genetic   change   that   is  passed  on   to   the  next  
generation.  It  is  most  clearly  revealed  in  the  E.  coli  type  I-­‐‑E  CRISPR-­‐‑
Cas  system,  which  recently  has  been  shown  to  have  a  strong  bias  for  
foreign   DNA   over   own   DNA,   thus   fulfilling   the   important  
Lamarckian   requirement   of   only   environmentally   induced   genetic  
changes   that  are  advantageous   to   the  organism  being   inherited  to   the  
next  generation  [79,  80].  
  
The  results  of  Paper  I  of  this  thesis  suggest  a  non-­‐‑random  generation  
of   adaptive   mutations.   There   are   Lamarckian   notes   to   the  
observations,   albeit   not   as   strong   as   for   CRISPR.   Koonin   and  Wolf  
(2016)   suggest   that,   rather   than   limiting   our   explanatory  models   to  
Darwinism   or   AIC,   evolution   should   be   seen   as   a   continuum   of  
processes,   encompassing   Darwinian,   Lamarckian   and   genetic   drift  
modules   [80].   From   this   perspective,   one   can   argue   that   having   a  
completely   random   approach   to   mutagenesis   under   stress   and  
starvation  would  be  wasteful   for   the  cell.  From  an  energy-­‐‑efficiency  
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point  of  view,  it  makes  sense  for  there  to  be  a  hierarchy  of  genes  that  
are   mutated   under   stress,   starting   with   transcriptional   regulators,  
rather   than   for   a   cell   to   sample   all   possible,   randomly   generated  
mutations.   Evolution,   it   seems,   is   not   always   the   process   of   neo-­‐‑
Darwinian   random  mutagenesis   and   selection,   but   uses   a   complex  
web  of  mechanisms  containing  also  the  modules  of  AIC  and  genetic  
drift.      
  
2.4.2  Evolution  and  synbio  
As   mentioned   in   the   introduction,   the   desire   for   control   that   is  
fundamental   in   engineering   of   biological   systems   conflicts  with   the  
inherent   capacity   of   living   systems   to   change   and   evolve.   Perhaps,  
though,   it   is   possible   to   take   the   opposite   standpoint,   and   harness  
organisms’   adaptation   capacity   in   synbio   constructions.   As   pointed  
out   by   Christina   D.   Smolke   in   a   discussion   paper,   “mutation   and  
evolution   were   widely   viewed   as   an   obstacle   […],   whereas   newer  
approaches  are  beginning   to  exploit   this  unique  aspect  of  biological  
systems  and  to  design  for  evolution  and  adaptation”  [17].    
  
For   genes   to   evolve   a   capacity   to   evolve   is   a   fundamental   paradox,  
but  may  still  be  true.  There  are  in  fact  several  systems,  such  as  error-­‐‑
prone   repair,   that   through   history   have   evolved   in   spite   of   their  
functions   as  mutation-­‐‑causers   [50,   81].   Our   Paper   I   study   points   to  
certain   mutational   mechanisms   being   dominant   at   different   time  
points,   and   the   mutagenesis   mechanism   is   strongly   linked   to   the  
precise   DNA   sequence.   This   highlights   the   potential   to   use  
knowledge   of   evolution   mechanisms   for   design   of   genes   and  
organisms   to   either   resist   or   exploit   adaptive   mutation.   When   we  
understand  how  DNA  mutates,  we  can  use  it:  e.g.  in  a  process  where  
8-­‐‑oxoG   can   be   assumed   to   be   a   dominating   mutation   mechanism,  
varying   the   G   content   of   individual   codons   can   be   a   method   to  
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increase  or  decrease   evolvability   of   a  gene.  One  might   speculate   that  
nature   has   done   this   with   important   genes,   or   that   8-­‐‑oxoG   is   a  
mechanism   developed   by   nature   to   increase   diversity   over   time.  
Further,   although   seemingly   very   different,   knowledge   of   adaptive  
changes   in   ageing,   stressed   bacterial   cells   might   be   relevant   for  
eukaryotic  ageing  and  tumour  biology  [50].       
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Chapter  3  
From   observation   to   creation   –   putting  





The   ultimate   goal   of   synthetic   biology   is   to   build  de  novo   biological  
systems   that   are   capable   of   carrying   out   whichever   tasks   we   have  
designed   them   for.   Until   we   reach   that   point,   much   of   synthetic  
biology  revolves  around  modifying  and  adjusting  existing  biological  
entities  to  serve  our  needs.  One  such  application  is  making  use  of  the  
cell   machinery   for   the   construction   of   whole-­‐‑cell   catalysts   using  
surface  display  technology.    
  
3.1  The  different   compartments   of   an  E.   coli   cell   and  
why  to  go  there  
While  E.  coli  was  historically  seen  as  a  unicellular  prokaryote  lacking  
any   compartmentalised   structures,   this   view   has   changed  
considerably.  The  E.  coli  cell  has  multiple  marked  off  compartments:  
the   inner   and   outer   membranes,   the   periplasm   and   the   cytoplasm.  
Additionally,   there   is   a   high   degree   of   organisation   of   protein  
networks   and   complexes   that   carry   out   various   tasks,   for   example  
proteins   involved   in   cell   division   and   cell   shape   maintenance,   or  
machineries   for   protein   folding   and   secretion   [82].   Taken   together,  





3.1.1  The  cell  and  its  membranes  
E.  coli  is  a  2  µμm  long,  rod-­‐‑shaped  bacterium  (Figure  7).  Being  a  Gram  
negative,   it   has   two   membranes,   inner   (IM)   and   outer   (OM),  
separated   by   the   periplasmic   space   and   a   peptidoglycan   layer.  
Together  they  protect  the  bacterium  from  the  outer  milieu,  and  give  
the   cell   rigidity.   The   inner   and   outer   membranes   differ   in   their  
composition,  with   the   two   IM   leaflets  having   the   same   composition  
of  mainly  phosphatidylethanolamine  (PE)  lipids  [83,  84].  In  contrast,  
the  OM’s   leaflets  differ   from  each  other.  The   inner   leaflet   looks   like  
the   IM   leaflets,   whereas   the   outer   leaflet   contains   endotoxins   also  
known   as   lipopolysaccharides   (LPS).   These   consist   of   lipid   A  
molecules   linked   to   oligosaccharides   and   variable   O-­‐‑antigen  
polysaccharides,   and   function   both   as   stabilisers   of   the   membrane  
and  immune  response  activators  in  many  animals  [85].    
Figure  7.  The  E.  coli  cell.  Important  compartments  are  marked,  and  include  
the   inner   and   outer   membranes   separated   by   the   periplasm   and   its  
peptidoglycan   layer,   chromosomal   and   plasmid   DNA   contained   in   the  
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In   addition   to   lipids   and   LPS,   E.   coli’s   membranes   consist   of   large  
numbers   of   proteins.   Membrane   proteins   constitute   an   immensely  
interesting   group   of   proteins,   responsible   as   they   are   for   crucial  
functions   like   transport,   adhesion   and   virulence.   In   fact,   genomic  
data  analysis  predicts  that  around  25%  of  the  genes  in  any  organism  
code   for   integral   membrane   proteins   [86].   Their   importance   is  
illustrated   by   the   fact   that   more   than   50%   of   all   drugs   target  
membrane   proteins   [87,   88].   In   the   minimal   genome   recently  
presented  by   the  Venter   lab,  18%  of   the  473  genes  were  membrane-­‐‑
related  [89].  One  synbio  effort  that  makes  use  of  membrane  proteins  
is  that  of  surface  display.    
  
3.1.2  Surface  display  
In   surface   display   technology,   specific   membrane   proteins   are  
employed  for  placing  a  passenger,  typically  a  protein  with  enzymatic  
activity,   on   the   outside   of   the   cell,   anchored   to   the   cell  membrane.  
The   principal   benefits   of   this   technology   include   simplified   down-­‐‑
stream   processing   due   to   easy   access   to   enzyme   and   product,  
potential   circumvention   of   toxicity   from   intermediates   or   product,  
and   a   highly   useful   link   between   phenotypic   and   genotypic  
characteristics.   Phage   display,   fusing   a   peptide   to   the   phage’s   coat  
protein   and   thereby   obtaining   its   co-­‐‑display   on   the   surface   of   the  
phage,   became   a   standard   technique   for   display   of   recombinant  
polypeptide   libraries   after   it   was   first   reported   in   1985   [90].  
Applications  are  centred  on  the  study  of  protein-­‐‑protein  interactions  
with   screening   of   antibody   libraries   for   the   identification   of   highly  
specific  therapeutic  antibodies,  a  key  technique  in  the  pharmaceutical  
industry  [91].  Bacterial  systems,  using  both  Gram-­‐‑positive  and  Gram-­‐‑
negative   species,   have   subsequently   been   developed   and   used   for  
purposes   such   as   vaccine   development,   antibody   epitope   mapping  
and   bioremediation   [92,   93].   A   major   focus   of   bacterial   surface  
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display   research   is   to   construct   whole-­‐‑cell   catalysts   by   displaying  
enzymes   that  can  act  on  various  substrates   interesting   for   industrial  
applications  [94].  
  
A  recurring  difficulty  with  surface  display  is  the  detection  of  surface-­‐‑
presented  protein,  and  this  problem  is  what  we  addressed  in  Paper  II  
of   this   thesis.  We   fused   the  displayed  protein   to   a   type  of   antibody  
molecule  specific  for  green  fluorescent  protein  (GFP),  which  allowed  
its  easy  detection.  In  surface  display  technology,  a  cell’s  translocation  
machinery   is  harnessed,  and  a   sub-­‐‑goal  of   the   technology  described  
in  Paper  II  was  for  our  method  to  allow  systematic  study  of  precisely  
those  molecular  mechanisms.    
  
3.2  The  different   compartments   of   an  E.   coli   cell   and  
how  to  get  there  
Around   40%   of  E.   coli   peptides   are  moved   from   the   cytosol   where  
they   are   made,   and   either   inserted   into   the   inner   membrane,  
transported   to   the   periplasm,   brought   to   the   outer   membrane,   or  
secreted   [95].   There   are   several   sophisticated   machineries   for  
enabling   the   translocation   of   proteins   across   the   different   barriers,  
some   better   understood   than   others.   The   β-­‐‑barrel   assembly  
machinery   (BAM),   responsible   for   insertion   of   outer   membrane  
proteins  into  the  outer  membrane,  is  still  to  a  large  extent  a  mystery.    
  
For   an   outer   membrane   protein   (OMP),   the   journey   across   the   cell  
wall  starts  with  an  N-­‐‑terminal  signal  peptide  directing  the  protein  to  
its   translocation   machinery,   continues   via   one   of   the   translocation  
pathways   across   the   inner   membrane,   followed   by   chaperone-­‐‑
assisted   transport   through   the   periplasm,   and   finally   finishes   with  
BAM-­‐‑assisted   outer   membrane   insertion.   An   overview   of   the  
translocation  pathways  is  presented  in  Figure  8.    
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Figure  8.  Translocation  paths  in  E.  coli.  Transport  of  a  protein  to  one  of  the  
membranes   utilises   four   major   systems.   Folded   protein   translocation   is  
achieved   by   the   Tat   (Twin-­‐‑arginine   translocation)   pathway.   Unfolded  
proteins  are   transported  across   the   IM  by   the  SecYEG  complex  assisted  by  
SecDFYajC.  SecB  sometimes  assist  in  the  transportation  of  protein  to  the  IM  
and  SecA  provides  energy   for   the  process  via   its  ATPase  activity.  The  SRP  
(signal  recognition  particle)  pathway  transports  proteins  that  are  still  being  
translated   to   SecYEG,   where   the   protein   is   translocated   using   the   energy  
from  translation.  Inner  membrane  proteins  (IMPs)  are  moved  into  the  IM  by  
the  action  of  YidC,  either  together  with  or  without  SecYEG.  Chaperones  Skp,  
SurA  and  DegP  are  important  for  the  transport  of  outer  membrane  proteins  
(OMPs)  across  the  periplasm  and  to  the  BAM  complex,  which  inserts  OMPs  














3.2.1  Translocation  across  the  inner  membrane    
Transport   across,   and   insertion   of   inner  membrane   proteins   (IMPs)  
into,   the   inner  membrane   uses   one   of   three  major  machineries:   the  
twin-­‐‑arginine   translocation   (Tat)   pathway   for   fully   folded   proteins,  
the   SecYEG   complex   for   unfolded   substrates   and   IMP   insertion,   or  
the  YidC  insertase,  which  inserts  IMPs  into  the  IM  alone  or  together  
with  SecYEG.    
  
Proteins   that   are   to   be   moved   to   the   IM   or   beyond   contain   an   N-­‐‑
terminal   signal   peptide   that   directs   them   to   their   respective  
translocation   pathway.   The   signal   sequence   is   later   cleaved   by  
periplasmic   peptidases   [97].   The   Tat   pathway   only   transports   fully  
folded   proteins   through   the   TatABC   translocase   [98].   These   are  
typically  co-­‐‑factor-­‐‑dependent  proteins,  since  co-­‐‑factors  can  mainly  be  
supplied  in  the  cytoplasm  [99].      
  
Unfolded  peptides  are  targeted  to  the  SecYEG  translocon,  responsible  
for   translocation  of   around  90%  of   secreted  proteins,   either  post-­‐‑   or  
co-­‐‑translationally.   Post-­‐‑translational   targeting   to   SecYEG   is  
sometimes   mediated   by   the   SecB   chaperone,   preventing   folding   of  
the   petide  while   it   is   transported   to   SecYEG,   but   can   also   be   SecB-­‐‑
independent.  When   the  protein  has   reached   the  Sec   translocon,   it   is  
pushed  through  using  energy  from  the  SecA  ATPase  [100].  The  SRP  
(signal   recognition   particle)   pathway   is   responsible   for   co-­‐‑
translational   targeting   of   peptides   to   the   Sec   translocon.   After  
binding   to   the   N-­‐‑terminal   signal   sequence   of   a   ribosome-­‐‑nascent  
chain  complex  (RNC),  SRP  is  recognised  by  its  receptor  FtsY  and  the  
RNC  directed  to  the  IM  and  the  Sec  translocase.  The  peptide  chain  is  
moved  through  the  Sec  translocon  in  a  way  that  is  thought  to  utilise  
the  energy  from  protein  synthesis  rather  than  from  SecA  [100].  Inner  
membrane  proteins  are  most  often  targeted  to  the  SRP  pathway  [99]  
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but  after  docking  of  the  RNC  to  SecYEG,  YidC  mediates  insertion  of  
the   protein   into   the   inner  membrane   [96].   The   opening   of   a   lateral  
gate  in  SecYEG  enables  this  movement  [99].  Certain  inner  membrane  
proteins  can  be  inserted  only  with  YidC,  without  SecYEG  mediation  
[96].   Additional   proteins   are   important   but   in   somehow   unclear  
ways:   SecDFYajC   seems   to   have   a   role   in   SecYEG-­‐‑mediated  
translocation,  and  YidD  has  been  shown  to  be  a  partner  for  YidC  [96].  
  
3.2.2  Transport  through  the  periplasm  
When   a   protein   has   reached   the   periplasm,   the   N-­‐‑terminal   signal  
sequence   is   cleaved   off,   and   the   protein   either   resides   in   this  
intermembranic  space,  or  is  transported  to  the  outer  membrane.  The  
periplasmically   located  mechanisms   are  much   less  well-­‐‑understood  
than   their   cytoplasmic   and   inner   membrane   counterparts,   but  
chaperones   are   essential   for   delivering   outer  membrane   proteins   to  
the  BAM  complex  [101].    
  
Three   chaperones   have   been   identified   as   key   players   in   transport  
through  the  periplasm  of  E.  coli:  Survival  protein  A  (SurA),  Seventeen  
kilodalton   protein   (Skp)   and   DegP   [102–104].   SurA   is   the   only   one  
whose  absence  causes  a  reduction  in  the  number  of  outer  membrane  
proteins,  and  it  has  been  suggested  that  SurA  is  the  main  chaperone  
used  by  outer  membrane  proteins,  while   they  make  use  of  Skp  and  
DegP  when   necessary   [104].   Remarkably,   there   is   no  ATP-­‐‑based   or  
electrochemical   energy   available   in   the   periplasm,  meaning   that   all  
actions   carried   out   by   chaperones   and   later   by   the   BAM   complex  
have  to  do  without  [104].  The  roles  of  the  chaperones  are  only  partly  
known,   but   SurA   and   Skp   have   been   shown   to   have   general  
chaperone   activity,  meaning   that   they   bind   to   unfolded,   but   not   to  
folded,  proteins.  SurA  also  interacts  directly  with  the  BAM  complex.  
DegP   studies   have   reported   contradicting   results,   showing   both  
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general   chaperone   activity,   and  protease   activity   for   degradation   of  
misfolded   or   aggregated   proteins   [105,   106].   Skp   and   SurA   deliver  
the  protein  to  BAM,  which  is  thought  to  recognize  the  so-­‐‑called  beta-­‐‑
motif   on   the   C-­‐‑terminal   strand   of   OMPs   as   a   signal   for   outer  
membrane  insertion  [107].  
  
3.2.3  Outer  membrane  insertion  
The   final   step   of   outer   membrane   protein   biogenesis,   the   actual  
insertion   of   the   protein   into   the   outer   membrane,   is   yet   more  
enigmatic   than   the   periplasmic   chaperone   mechanisms.   The   BAM  
complex   is   required   for   the   process,   and   its   only  OMP   component,  
BamA,   is   one   of   just   two   essential   OMPs   in   E.   coli   [104,   108].   In  
addition  to  BamA,  the  BAM  complex  consists  of  the  four  lipoproteins  
BamB,  BamC,  BamD,  and  BamE.  BamA  forms  a  beta-­‐‑barrel  structure  
in   the  membrane,  while   BamB-­‐‑E   are   associated  with   the  membrane  
via  an  N-­‐‑terminal  lipid  modification  [109,  110].  BamA  and  BamD  are  
the  only  essential  components  of   the  complex.  Two  models  exist   for  
the  insertion  of  an  OMP  into  the  membrane  by  the  BAM  complex:  the  
BamA-­‐‑assisted   model   and   the   BamA-­‐‑budding   model.   The   prior   is  
supported   by   most   scientific   evidence,   and   suggests   that   the   BAM  
complex  primes  the  membrane  by  thinning  it  and  destabilising  lipids.  
When  an  OMP  is  then  delivered  by  SurA  or  Skp,  it  can  spontaneously  
integrate   into   the   membrane.   The   BamA-­‐‑budding   model   instead  
proposes   that   the   BAM   complex   pulls   the  OMP   through   its   central  
BamA  barrel   domain,   and   then   lets   it   out   into   the  membrane   via   a  
lateral   gate,   similar   to   the   SecYEG-­‐‑YidC-­‐‑based   insertion   of   IMPs  
[104].    
    
Independently   of   the   exact   details   of   the   mechanisms   described   in  
this   section,   it   is   clear   that   the   transport   of   a   protein   from   the  
cytoplasm   all   the   way   to   the   outer   membrane   is   a   very   complex  
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process.  Using   the  described   translocation  machineries   for   synthetic  
biology   applications   involves   big   challenges,   as   well   as   big  
opportunities   to   learn   more   about   the   mechanistic   details   behind.  
Analogous   to   how   the   development   of   a   GFP   platform   greatly  
facilitated   membrane   protein   production   and   studies   [111–114],  
simple   assays   for   the   study   of   surface   display   and   associated  
translocation  mechanisms  are  needed.  
  
3.3  Major  OM  anchors  and  their  structure    
When   it   comes   to   exploitation   of   the   cell   machinery   for   surface  
display  of  a  protein  of  choice,  many  different  systems  and  organisms  
have  been  explored.  Two  of  the  main  anchor  types  used  for  bacterial  
surface   display,   and   the   ones   chosen   in   Paper   II   of   this   thesis,   are  
autotransporters  (ATs)  and  Outer  membrane  protein  A  (OmpA).    
  
3.3.1  Autotransporters  
Autotransporters   constitute   the   Type   V   secretion   system,   which   is  
commonly   found   in   Gram-­‐‑negative   bacteria.   Autotransporters  
typically   function   as   virulence   factors   with   cytotoxic,   adhesive,   or  
proteolytic   effects   [115].   They   also   have   roles   in   biofilm   formation  
and   immune   system   evasion.   The   classic   structure   of   an  
autotransporter  protein  is  an  N-­‐‑terminal  signal  peptide,  followed  by  
a  passenger  domain   that  will  be  secreted   to   the  outside  of   the  outer  
membrane,  and  lastly  a  C-­‐‑terminal  translocation  unit  (Figure  9).    
  
Autotransporters   are   translocated   across   the   inner   membrane   by  
means   of   the   SecYEG   complex,   via   the   SecA-­‐‑dependent   pathway.  
Both   the   SurA   and   Skp   chaperones   have   been   shown   to   assist   the  
transport  across  the  periplasm  [116].  Then,  with  help  from  the  BAM  
complex,  the  C-­‐‑terminus  of  the  autotransporter  is  first  assembled  into  
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the   outer   membrane,   after   which   the   passenger   domain   is   pulled  
through  the  translocation  unit.  
  
Figure  9.  Autotransporter  structure.  Autotransporter  proteins  consist  of  an  
N-­‐‑terminal  signal  peptide  (SP)  for  direction  to  the  translocation  machinery,  
a  C-­‐‑terminal  translocation  unit,  and  a  passenger  that  is  N-­‐‑terminally  linked  
to  the  translocation  unit.  The  signal  peptide  is  cleaved  off  after  translocation  
of   the   autotransporter   into   the   periplasm.   Chaperones   assist   in   transport  
across   the  periplasm  and   the  passenger  protein   is  moved   to   the   surface  of  
the  cell  after  insertion  of  the  translocation  unit  into  the  OM.    
  
When   on   the   outside   of   the   cell,   the   passenger   is   either   cleaved,  
attaches  to  another  site  on  the  outer  membrane,  or  remains  bound  to  
the  translocation  unit  [117].  The  synthetic  biology  field  has  explored  
autotransporters  for  the  use  of  bringing  various  passengers  to  the  cell  
surface;   examples   include   lipases,   dehydrogenases   and   a   bacterial  
cytochrome  P450  enzyme  [118–120].  
  
SP Passenger Translocation unitLinkerN C
OM
IM
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3.3.2  Outer  membrane  protein  A  
Outer  membrane  protein  A  is  a  major  outer  membrane  protein  in  E.  
coli,   existing   in   some   100,000   copies   per   cell   [121].   It   forms   a   beta-­‐‑
barrel   with   eight   transmembrane   segments.   OmpA   serves   a  
multitude  of  functions,  including  general  porin  activity  and  structure  
stabilisation   (Figure   10)   [122,   123].   In   addition,   it   is   the   receptor   for  
bacterocins   and   bacteriophages,   while   also   acting   in   adhesion   and  
invasion  itself  [123,  124].    
  
Figure  10.  Outer  membrane  protein  A.  Structure  of  OmpA  (PDB  ID  1bxw).  
Image  created  with  the  UCSF  Chimera  Package  [125].    
  
Many   studies   have   been   made   on   the   use   of   OmpA   in   synthetic  
biology,  not   the   least  on   the   fusion  version  of   the  protein  known  as  
LppOmpA.  This  hybrid  protein  consists  of   the  signal  peptide  of   the  
lipoprotein   Lpp,   fused   to   five   transmembrane   segments   of   OmpA  
[126].   It   is   translocated   across   the   inner   membrane   using   the   Sec  
machinery  and  the  SRP-­‐‑dependent  pathway.  Interestingly,  YidC  also  
seems   to   play   a   role   [127].   The   LppOmpA   anchor   has   been  
extensively   explored   for   surface   display   by   C-­‐‑terminal   fusion   of   a  
passenger   to   the   hybrid   protein,   and   examples   in   E.   coli   include  
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display   of   hydrolases,   lipases   and   single-­‐‑chain   variable   fragments  
(scFvs)  [128–130].    
  
3.4  Harvesting  nature’s  designs:  nanobodies  and  green  
fluorescent  protein  
In   the   development   of   new   synbio   technologies,   there   is   an  
astonishing   potential   to   find   suitable   solutions   among   those   that  
nature  has  already  evolved.  In  Paper  II  of  this  thesis,  we  make  use  of  
two  outstanding  molecules   found   in  nature,  and  combined  with   the  
outer  membrane  protein  machinery  of  E.  coli   they  form  the  basis  for  
construction  of  a  new  surface  display  platform.   In   the   search   for  an  
easy   way   to   detect   surface   display,   it   is   tempting   to   use   GFP   as   a  
reporter   [131].   This,   however,   is   a   dubious   strategy   due   to   the  
difficulty   to   discriminate   between   intracellularly   and   surface  
localised   GFP.   In   Paper   II   of   this   thesis,   we   solve   this   problem   by  
combining  GFP  with  a  nanobody  (NB)   in  a  new  strategy  for  surface  
display  detection.    
  
3.4.1  Green  fluorescent  protein  
Deep   down   in   the   seas,   many   creatures   look   exotic   from   the  
perspective   of   us   who   walk   above   ground,   and   transparent  
organisms  with  luminous  parts  are  mainstream.  In  these  waters,   the  
Aequorea  victoria  jellyfish  swims,  glowing  intensely  green.  This  caught  
the   attention   of   Japanese   researchers   in   the   1960s,   and   led   to   the  
nowadays   very   frequent   usage   of   GFP   in   cell   biology   and  
biotechnology.   The   history   is   slightly   brutal,   with   the   later   Nobel  
prize-­‐‑awarded   Osamu   Shimomura   for   19   years   spending   the  
summers  catching  vast  numbers  of  jellyfish  (850,000  in  the  end)  from  
which  the  fluorescing  protein  was  cut  out  [132].  
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Many   years   after   Osamu   Shimomura’s   isolation   of   the   protein,  
Martin  Chalfie,  another  Nobel  laureate,  in  1994  succeeded  in  cloning  
and   expressing   the   GFP-­‐‑encoding   gene   in   both   E.   coli   and   the  
nematode   worm   C.   elegans   [133].   This   was   the   start   of   a   GFP  
revolution,   and  we   have   since   seen   both   fluorescing   cats   and  mice  
[134].  In  biotechnology,  GFP  is  typically  used  as  a  reporter,  showing  
for   example   when   and   where   a   gene   is   expressed,   and   it   has   also  
been  instrumental   for  optimisation  of  membrane  protein  production  
[114].   GFP   has   been   used   to   study  many   fundamentally   important  
processes   in   biology   such   as   cell   division   and   inner   membrane  
protein  topology  [111,  135].  Precisely  the  localisation  aspect  was  what  
we  used  in  the  study  in  Paper  II  of  this  thesis.  GFP  is  a  useful  tool  not  
only  because  of  its  fluorescence,  but  also  because  it  is  a  highly  stable  
protein   that   is   easy   to  produce  and  work  with   in   the   laboratory.   Its  
value   is   in   essence   that   it   enables   the   visualisation   of   the   normally  
invisible,   a   capacity   that   anyone   working   with   microorganisms,  
proteins  and  genes  can  appreciate  (Figure  11).    
Figure  11.  Green  fluorescent  protein  in  the  lab.  GFP  enables  visualisation  
of  protein  (A)  in  cell  culture,  (B)  on  protein  gels,  and  (C)  in  microscopy.    
  
3.4.2  Nanobodies  
Another   example   of   remarkable  molecules   are   the   tiny   single-­‐‑chain  
antibodies   found   in   sharks   as   well   as   camelid   species   (camels,  
A B C
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dromedaries,   llamas),   which   due   to   their   relatively   small   size   are  
called  nanobodies.  These  heavy-­‐‑chain-­‐‑only  antibody  molecules  were  
first  reported  in  camel  serum  in  1993  and  subsequent  characterisation  
of  NBs  has   shown   their  potential   for  use  as  both   therapeutic  agents  
and   biotechnological   alternatives   to   conventional   antibodies   [136].  
Nanobodies   are   around   12   kDa   in   size   and   carry   out   the   normal  
antibody   functions,   in   spite   of   being   just   a   fraction   of   the   size   of   a  
conventional  antibody  (Figure  12).    
  
Figure   12.   Antibody   versus   nanobody.   Conventional   antibodies   (left)  
consist  of  two  heavy  chains  (blue)  and  two  light  chains  (orange),   linked  by  
disulphide   bonds.   Nanobodies   (right)   consist   of   only   one   heavy   variable  
domain.    
  
NBs   bind   with   high   specificity   and   affinity   to   their   antigens,   after  
which  they  recruit  the  immune  response  apparatus  in  order  to  attack  
the   foreign   molecule.   Their   epitopes   differ   from   those   of   ordinary  
antibodies   in   that   NBs   are   more   often   targeting   concave   epitopes,  
typically   found   in   the  active   site  of   enzymes   [137].  Hence,  NBs  also  
often   modify   the   activity   of   their   protein   antigen   [137–139].   Their  
antigen   binding   affinity   is   in   the   nanomolar   range,   comparable   to  
high-­‐‑affinity   antibodies   and   similar   to   that   of   scFvs   [140].  
Furthermore,   they   are   highly   soluble,   very   stable,   and   easily  
produced  in  heterologous  hosts  [140,  141].  The  desired  binder  can  be  
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selected   via   phage   display   but   nature’s   own   method,   with   prior  
immunisation  of  a  camel,   is  recommended  to  achieve  higher  affinity  
NBs  [140,  142,  143].  The  many  advantageous  properties  of  NBs  have  
sparked  their  use  for  therapeutic  methods  as  well  as  biotechnological  
purposes  [144,  145].    
  
3.4.3  GFP  and  GFP-­‐‑NBs  
In   2010,   Kirchhofer   et   al.   injected   a   camel   with   GFP,   collected   its  
nanobody   repertoire   from   the   B-­‐‑lymphocytes,   and   cloned   it   into   a  
phagemid   library   subsequently   used   to   select   GFP-­‐‑binders   [143].  
Specifically,   they   isolated   an   enhancer-­‐‑NB,   increasing   GFP’s  
fluorescence  10-­‐‑fold,  and  a  minimiser-­‐‑NB  causing  GFP’s  fluorescence  
to  decrease  by  a  factor  five.  Together,  these  findings  resulted  in  a  new  
toolbox  consisting  of  GFP  and  two  nanobodies,  capable  of  modifying  
GFP’s  fluorescence  properties.  The  affinity  of  NB  to  GFP  is  very  high,  
and   remarkably,   the   interaction   is   highly   stable.   As   described   in  
Paper   II,   this   enables   analysis   of   a   GFP-­‐‑NB   complex   with   many  
different  methods,  such  as  denaturing  protein  gels  (Figure  13).  
  
  
Figure  13.  GFP-­‐‑nanobodies’  effect  on  GFP.  In-­‐‑gel  fluorescence  shows  how  
GFP  binds  to  both  enhancer-­‐‑NB,  resulting   in  a   fluorescent  complex,  and  to  









In  Paper  II  of  this  thesis,  we  exploited  the  GFP:nanobody  interaction  
for  development  of  a  new  platform  for  detection  of  surface  displayed  
protein.  The  enhancer-­‐‑nanobody  is  in  this  method  fused  to  a  surface  
anchored  enzyme  and  subsequently  detected  and  analysed  using  free  
GFP.  In  this  way,  knowledge  from  basic  biological  research  is  used  to  
adjust   a   living   cell   according   to   our  needs,  while   in   a   double   sense  
making  use  of  the  clever  systems  already  developed  by  nature.    
  
Interestingly,   we   observed   large   differences   in   display   efficiency  
between   the  OmpA  anchor   and   the   autotransporter   anchor  C-­‐‑IgAP,  
and  also  a  cargo-­‐‑dependency.  We  hypothesise  that  this  is  partly  due  
to   differences   in   the   translocation   paths   taken,   which   in   turn   is  
dependent   on   the   choice   of   anchor   and   signal   peptide.   This  
hypothesis  is  supported  by  a  test  of  a  small  library  of  signal  peptides’  
effect   on   surface   display,   showing   a   clear   impact   for   especially   the  
autotransporter   anchor.   The   library   contained   signal   peptides   for  
direction   to   the   Tat,   SecB   and   SRP-­‐‑dependent   translocation  
pathways,  and  our  comparison  showed  an  anticipated  disadvantage  
of  using  the  Tat  pathway.  The  experiment  highlighted  how  balancing  
of  the  different  components  involved  is  crucial  for  successful  display;  
illustrating   this   is   the  observation   that   the   signal  peptide  giving   the  
highest   display   when   produced   from   a   low-­‐‑copy   plasmid   was   no  
longer  beneficial  in  a  different  backbone.    
  
In   general,   we   observed   difficulties   for   the   cell   to   produce   the  
autotransporter   C-­‐‑IgAP.   The   fact   that   OmpA   is   an   E.   coli   protein  
whereas  C-­‐‑IgAP  is  not  might  be  part  of  the  explanation.  Additionally,  
the   observations   could   potentially   be   due   to   saturation   of   the  
translocation  machinery,  an  imbalance  that  is  presumably  relieved  by  
adding   the   enzyme   Chitinase   A   to   the   protein   fusion.   One   can  
speculate   that   the   autotransporter   protein   sequence,   with   the  
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passenger   always   being   N-­‐‑terminal   to   the   translocation   domain,  
leads  to  the  passenger  having  an  increased  influence  on  translocation  
efficiency.  
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Synthetic  biology  offers   the  opportunity  to  explore  and  make  use  of  
the   clever   solutions   existing   in   the   natural   world   around   us.   This  
thesis  is  about  the  two  pillars  of  synthetic  biology,  and  how  they  can  
be   used   to   understand   and   (re)construct   living   systems.   The   work  
underlying   the   thesis   spans   from   increasing   our   understanding   of  
how   Escherichia   coli   adapts   to   a   challenging   environment,   to   using  
characterised   parts   of   the   same   organism   for   the   clear  
biotechnological  purpose  of  surface  display.    
  
Paper  I  describes  the  study  of  adaptive  mutation  formation  in  ageing  
E.   coli   cells.   It   reveals   the   occurrence   of   non-­‐‑random   mutagenesis  
patterns  when  cells  are  starved  for  an  extended  time.  This  paper  casts  
new  light  on  the  complex  mechanisms  behind  adaptive  mutagenesis,  
a   phenomenon   that   nevertheless   remains   occult.   Many   follow-­‐‑up  
experiments   are   presently   on-­‐‑going   in   our   lab,   investigating   the  
importance   of   codon   usage   for   the   mutability   of   genes,   deepening  
our  understanding  of  the  timeliness  of  different  mutation  types,  and  
exploring   the   possibility   of   designing   a   protein   for   mutation   and  
evolution.    
  
In  Paper  II,  mechanisms  that  to  a  large  extent  have  been  deciphered  
are  used  for   the  development  of  a  new  surface  display  platform.  By  
combining   GFP   and   nanobodies,   we   address   the   need   for   an   easy  
detection  system.  In  parallel,  we  used  the  new  assay  for  evaluation  of  
signal   peptide   influence   on   display   efficiency,   and   also   observed  
large   differences   in   display   levels   depending   on   the   anchors   and  
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passengers  used.  A  future  prospect  is  for  the  surface  display  platform  
to  be  a  robust  tool  for  applied  as  well  as  fundamental  studies,  linking  
application   with   basic   science.   Our   hope   is   that   the   platform   can  
extend   to   the   basics   of   synbio   and   be   used   to   deepen   the   current  
knowledge   of   translocation   mechanisms   such   as   those   associated  
with   the   still   mysterious   BAM   complex.   For   biotechnological  
developments,   future   uses   should   include   strain   optimisation   and  
screening.  For  example  one  could  envision  screening  mutant  libraries  
for  better  surface  display  with  our  approach.  
  
The  study  of  mutation  generation  in  a  whole-­‐‑genome  context  would  
not   have   been   possible  without   the   recent   advances   in   sequencing,  
with   Next   generation   sequencing   (NGS)   becoming   affordable   and  
thereby   accessible   at   a   new   scale.   Rapid   decreases   in   prices   for  
important   technologies   have   indeed   been   instrumental   for   their  
widespread  use  throughout  the  synbio  community,  all  the  way  to  the  
new   citizen   scientists   and   do-­‐‑it-­‐‑yourself-­‐‑biologists.   Similar   to   the  
development   of   computer   science   and   technology,   democratising  
synbio   technology   might   be   a   recipe   for   success   and   scientific  
progress.  From  that  perspective,  a  particularly  positive  feature  of  the  
NB:GFP   platform   is   that   GFP   is   easily   and   cheaply   produced   in  E.  
coli,   making   the   assay   possible   to   perform   in   any   lab.   In   the   open-­‐‑
source   spirit   of   synbio,   our   assay   makes   surface   display   analysis  
more  accessible,   facilitating  developments  of   this   technology  as  well  
as  studies  of  the  underlying  translocation  mechanisms.    
  
This   thesis   illustrates   the   two   synbio   pillars   of   understanding   and  
constructing   organisms,   and   how   the   two   overlap   and   complement  
each   other.   By   pursuing   an   open-­‐‑minded   strategy   combining   basic  
and   applied   research,   synbio   constitutes   a   chance   to   create   the  
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sustainable  solutions  we  are  in  great  need  of.  The  work  presented  in  
this  thesis  will  hopefully  be  a  fruitful  contribution  to  this  quest.         
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Abstract    
How  do  ageing  bacterial  colonies  generate  adaptive  mutants?  Over  a  
period   of   two   months,   we   isolated   on   ageing   colonies   outgrowing  
mutants   able   to   use   a   new   carbon   source,   and   sequenced   their  
genomes.   This   allowed   us   to   uncover   exquisite   details   on   the  
molecular  mechanism  behind  their  adaptation:  most  mutations  were  
located  in  just  a  few  hotspots  in  the  genome  and  over  time,  mutations  
increasingly  originated  from  8-­‐‑oxo-­‐‑guanosine,  formed  exclusively  on  
the  transcribed  strand.    
  
Introduction    
Bacteria   constitute   a   precious   biological  model   system   for   studying  
the  molecular  details  of  ageing  and  evolution.  Bacterial  cells  defective  
in   the  MutY   enzyme,   responsible   for   removing   adenine  nucleotides  
pairing   with   the   8-­‐‑oxo   oxidized   variant   of   guanosine   (8-­‐‑oxo-­‐‑G),  
exhibit   a   dramatic   increase   in   the   number   of   adaptive  mutants   and  
Bridges  proposed  a  model  to  explain  this  phenomenon  that  was  later  
termed   retromutagenesis   [1,2].   In   this   model,   the   process   of  
transcription   opens   up   the   DNA   double   helix,   enhancing   the  
probability  of  mutation  in  the  transcribed  strand,  but  only  mutations  
on  the  transcribed  strand  are  transferred  to  mRNA  and  translate  into  
mutants   proteins   that   explore   novel   activities.   Subsequently,   the  
activity   of   the   mutant   protein   may   enable   the   cell   to   replicate   and  
thereby   fixes   the   initial  adaptive  mutation  on  both  DNA  strands.   In  
agreement  with   the   retromutagenesis  model,   lacZ   amber  mutations  
on  the  transcribed  strand  were  recently  isolated  in  approximately  10-­‐‑  
fold   excess   over   mutations   on   the   non-­‐‑transcribed   strand   upon  
treatment   with   the   mutagen   nitrous   acid   [3].   However,   the  
prevalence   of   this   molecular   mechanism   has   not   been   studied   in   a  
non-­‐‑mutator   background   and   has   not   been   validated   in   a   whole  
genome  context.    
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To   gain   new,   in-­‐‑depth   knowledge   of   the   mechanisms   behind  
adaptive   mutation   we   wanted   to   study   the   genetic   changes   in   a  
background   as   undisturbed   as   possible.   For   this   purpose,   we  
designed   an  E.   coli  strain   incapable   of   fermenting  maltose,   plated   it  
on  rich  medium  with  maltose,  and  subsequently  collected  all  mutants  
starting   to   outgrow   on   colonies   over   the   course   of   two   months  
(Figure  1).    
  
Figure   1.   Schematic   illustration   of   the   experimental   set-­‐‑up.   The   parental  
strain   is   incapable   of   using   the   carbon   source   available   in   the   plates,   but  
after   some   days   on   plates,   mutants   adapted   to   their   environment   appear.  




Aging   colonies   give   rise   to   mutants   in   a   non-­‐‑mutator-­‐‑based  
experimental  system    
Our   starter   strain   is   a   derivative   of   the  model   bacterium  Escherichia  
coli  K12  MG1655  with   its  cyaA  gene  deleted,  precluding  synthesis  of  
the  signalling  molecule  cyclic  AMP.  As  a  consequence,  a  great  many  
genes   involved   in   carbon   source   catabolism   cannot   be   expressed  
because  they  belong  to  operons  requiring  the  cAMP  Receptor  Protein  
(CRP)  complex  to  be  activated  [4].  These  cells  can  grow  for  some  time  
on  rich  media,  but,  after  having  used  the  accessible  sources  present  in  
the   available  medium   (MacConkey  medium),   the   cells   cannot   grow  
further  but  remain  as  small  colonies  caught  in  a  quiescent  state.    
parent strain time mutant growth NGSmutant selection
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Around   four   days   after   plating,   mutants   capable   of   fermenting  
maltose  started  to  appear  as  red  papillae-­‐‑like  structures  on  the  white  
colonies,   and   these  mutants   continued   to   appear   over   the   next   two  
months  as  some  cells  adapted  to  their  environment.  Mutant  papillae  
outgrew   on   approximately   one   in   200   colonies,   and   progressively  
invaded   the   surface   of   the   plate   (Figure   2a)  making   it   necessary   to  
start  with   a   large  number  of  plates   to  be   able   to   sample  mutants   at  
the  late  time  points.  All  mutant  strains  were  purified  and  displayed  a  
variety   of   phenotypes   on   different   carbon   sources   (Supplementary  
Table  1).    
  
Figure   2.  When   subjected   to   prolonged   incubation,  Escherichia   coli   K12  
MG1655   cyaA-­‐‑   cells   adapt   to   their   environment.   (a)  E.   coli   cyaA-­‐‑   cease   to  
grow  after  forming  small  white  colonies,  when  maltose  is  the  major  carbon  
source.  After  4-­‐‑  5  days  of  incubation,  mutants  start  occurring  as  red  papillae  
on   MacConkey   agar   (inserted   image)   and   continue   to   form   over  
approximately  6  weeks.  (b)  96  mutant  papillae  were  isolated,  phenotypically  
characterized   and   genome   sequenced.   Loci  with   less   than   three  mutations  
are   uniformly   distributed   on   the   circular   genome   as   illustrated  with   black  
lines.  Hotspots   of   genes  with  more   than   two  mutations   are   indicated  with  
double-­‐‑sized  black   lines  and  the   total  number  of  mutations   in  each  gene   is  
stated  within  brackets.  
!
a b
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Adaptive  mutations  are  located  in  specific  hotspot  genes    
We  sequenced  the  genomes  of  96  mutants,  spanning  the  whole  two-­‐‑
month  period,  and  identified  an  average  of  four  to  five  mutations  per  
genome,  the  majority  localized  in  a  few  hotspots  only  (Figure  2b  and  
Supplementary   Table   2).   The   hotspots   are   located   in   the   following  
genes   (Figure   2b):   cmk   (cytidylate   kinase),   crp   (cyclic   AMP   receptor  
protein),  malT   (activator   of   the   maltose   regulon   transcription),   rhlE  
(ATP-­‐‑dependent   DNA   helicase),   rpoS   (sigma   factor   sigma   38),   xseA  
(large  subunit  of  exonuclease  VII),  and  two  loci  that  are  known  to  be  
unstable   in   laboratory   strains;   e14-­‐‑icd   (e14   prophage   inserted   in   the  
NADP-­‐‑dependent   isocitrate   dehydrogenase   gene)   and   intR   (Rac  
prophage  integrase).    
  
From  the  way  the  experiment  was  constructed,   it  could  be  expected  
that  mutations  in  the  crp  gene  would  account  for  growth  on  maltose  
in  a  ΔcyaA  background.  However,   the  difficulty  of  obtaining  cAMP-­‐‑
independent   (crp*)  mutants  witnessed   by   Jon   Beckwith'ʹs   laboratory  
suggested   that  under  exponential  growth  such  mutations  were  very  
rare   (of   the  order  of  1   in  109   cells   [5]).   In   light  of   this,   the  ease  with  
which   we   obtained   such   mutations   in   resting   colonies   was   utterly  
unexpected.    
  
It  has  been  repeatedly  observed  that   in  E.  coli  laboratory  strains,   the  
rpoS  gene  is  often  inactivated  [6,7].  This  is  also  what  we  observed  at  
the  rpoS  hotspot  (point  mutations  in  general,  but  also  frameshifts  and  
a  deletion  of   the  region,  see  Supplementary  Table  2).   Inactivation  of  
the   RpoS   protein   may   have   triggered   an   increase   in   age-­‐‑related  
mutagenesis,   as   this   transcription   factor   is   involved   in   oxidative  
stress   response   during   stationary   phase   [8].   However,   before   we  
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understand  the  molecular  mechanism,  we  can  only  speculate  why  the  
remaining  hotspot  genes  are  targeted.    
  
The   majority   of   adaptive   mutations   take   place   on   the  
transcribed  strand    
Theoretically,  12  different  types  of  mutations  are  possible  in  DNA  (A-­‐‑
C/G/T,  C-­‐‑  A/G/T,  G-­‐‑A/C/T  or  T-­‐‑A/C/G),  but  it  is  established  that,  due  
to   respiration   under   stationary   phase   conditions,   8-­‐‑oxo-­‐‑G   induced  
mutations   are   the   most   frequent   to   occur   in   the   absence   of   an  
additional   mutagenic   process   [9,10].   In   line   with   this,   a   dominant  
proportion   of   the   mutations   that   were   observed   during   the  
generation   of   the   carbon-­‐‑positive   papillae   is   consistent   with   the  
involvement  of  8-­‐‑oxo-­‐‑G  (G-­‐‑T  and  C-­‐‑A  transversions,  69%  of  the  total  
number  of  missense  mutations,  Figure  3a).  A  large  proportion  of  the  
remaining  mutations  (28%  of  the  total  number  of  missense  mutations  
identified)  are   likely   the   result  of   cytosine  deamination   (G-­‐‑C   to  A-­‐‑T  
transitions,   Figure   3a),   another   common   mutational   event   in   non-­‐‑
dividing  cells  [9,11].    
  
Remarkably,   the  mutated   base   is   highly   dominantly   present   on   the  
transcribed   strand   within   gene   coding   sequences   (84%   for   G  
transversions   and   93%   for   C   deaminations,   Figure   3a).   Even   more  
extremely,  in  a  total  of  594  crp  variants  we  sequenced  from  different  
papillae,   99%   of   the   G   transversion   and   C   deamination   events   had  
taken  place  on  the  transcribed  strand  (Figure  3b).  These  observations  
are  consistent  with  an  increased  mutation  rate  in  transcribed  regions  
(see   Supplementary   Table   2)   and   strongly   support   the  
retromutagenesis  model   (Figure  3  c-­‐‑d)   [1,3,12]  –  here   in   the  absence  
of   a   mutagen.   Importantly,   the   extreme   strand   bias   considerably  
reduces  the  relevance  of  potential  residual  replication  and  growth  in  
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the   aging   colonies   –   a   heavily  debated,   but   hard   to   test,   part   of   the  
controversy  of  adaptive  mutations  [13].    
  
  
Figure   3.   8-­‐‑oxoguanine   formation   and   cytosine   deamination   are   highly  
dominating   on   the   transcribed   strand   in   isolated   papillae.   (a)   Assuming  
that  all  identified  G-­‐‑T  and  C-­‐‑A  transversions  are  the  result  of  8-­‐‑oxoguanine  
formation,   and   all   G-­‐‑C   to   A-­‐‑T   transitions   are   the   result   of   cytosine  
deamination,  we   analysed   the   localisation   of   the   corresponding  G-­‐‑   and  C-­‐‑  
residues  in  the  96  sequenced  mutant  genomes  and  in  (b)  the  594  sequenced  
crp   sequences.   Only   missense   mutations   were   analysed.   (c)   Upper   panel:  
Illustration   of   the   mechanism   of   retromutagenesis   after   8-­‐‑oxoguanine  
(encircled   G)   formation   on   the   transcribed   strand   (ts,   dark   grey   line)   that  
enables   insertion  of  an  adenine  ribonucleotide   in   the  mRNA  (green  waved  
line).   The  mutated  mRNA   enables   growth   and   a   round   of   replication   that  
permanently  fixes  the  mutation  on  the  coding  strand  (cs,   light  blue   line)   in  
daughter  cells.  Lower  panel:  8-­‐‑  oxoguanine  formation  on  the  coding  strand  
does  not  transfer  to  daughter  cells.  (d)  Illustration  of  retromutagenesis  after  
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cytosine   nucleotide   deamination   into   uracil   (encircled   U),   enabling   base  
pairing   with   A.   Upper   and   lower   panels   show   result   of   cytosine  
deamination   on   transcribed   and   coding   strand   respectively,   as   detailed   in  
(c).  
  
In   the   retromutagenesis   model,   mutations   generated   on   the  
transcribed  strand  are  selected  for.  In  contrast,  a  so-­‐‑called  hitchhiking  
mutation   is   per   definition   not   selected.   Are   the   other   hotspots  
selected   for   or   hitchhikers?   It   is   interesting   to   compare   the   specific  
nucleotide  changes  in  crp  that  occur  alone  (singles)  with  those  found  
only   in   combination   (paired)  with   a   crp*  mutation:   94%   (399   out   of  
423)   of   single   mutations   were   G   transversion   and   C   deamination  
events  on  the  transcribed  strand,  whereas  only  40%  (27  out  of  67)  of  
the   paired   mutations   were   of   this   type.   Furthermore,   the   1%   G  
transversions  and  C  transitions  found  on  the  non-­‐‑transcribed  strand  
(eight   events   in   total)   were   all   in   the   paired   positions.   Thus,   in  
contrast   to   the   crp*   mutations,   it   is   not   possible   to   decipher   the  
mechanism  leading  to  these  extra  mutations  in  crp.    
  
C  deamination  events  outside  crp  are  evenly  distributed  (50%  on  the  
transcribed   and   the   non-­‐‑transcribed   strand).   This   indicates   that   the  
other   C   deamination   events   are   not   caused   by   retromutagenesis.  
Apart  from  events  in  crp,  G  transversion  mutations  were  identified  in  
the  xseA,  cmk,  malT  and  rpoS  hotspots,  and  20  out  of  21  cmk  and  5  out  
of  5  xseA  G  transversions  had  taken  place  on  the  transcribed  strand.  
This   may   indicate   a   selective   advantage   of   these   mutants,   but  
hitchhiking   is   still   theoretically   possible   because   the   xseA   and   cmk  
genes  are  transcribed  from  the  same  (+)  strand  as  crp  on  the  genome  
and   thus  may   be   fixed   in   the   same   round   of   replication   as   the   crp*  
mutants   are.   In   contrast,   rpoS   mutations   must   have   a   selective  
advantage:  16  out  of  17  rpoS  G  transversion  missense  mutations  occur  
on   the   transcribed   strand,   but   the   rpoS   gene   is   placed   on   the  
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complement   (-­‐‑)   strand   and   thus   retromutagenesis  must   have   taken  
place  independently  of  crp*  generation.  Four  out  of  four  identified  G  
transversion   mutations   in   the  malT   hotspot   were   all   placed   on   the  
non-­‐‑transcribed   strand   and   thus   cannot   have   been   selected   by  
retromutagenesis.    
  
Formation  of  adaptive  mutations  shows  age-­‐‑dependence    
Time   is   an   important   factor   in   the   development   of  mutant   papillae  
and  the  sampling  of  adaptive  mutants  over  two  months  enabled  us  to  
observe   interesting   age-­‐‑related   trends.   Firstly,   a   minimum   of   four  
days  of  incubation  is  required  for  adaptive  mutations  to  occur  in  our  
experimental   setup.   Secondly,   the   frequency   of   papillae   with   rpoS  
mutations   increases   over   time,   suggesting   an   increasingly   selective  
advantage   with   age   (Figure   4a).   Alternatively,   the   mechanism(s)  
leading   to   rpoS  mutations   are   becoming  more  prominent   over   time.  
Thirdly,   G   transversion   mutations   in   crp   increases   over   time,  
paralleled  by  a  decrease  in  C-­‐‑deaminations  (Figure  4b).    
  
Our   observations   are   not   consistent   with   a   general   increase   in  
mutagenesis,  as  the  frequency  of  rifampicin  resistance  is  of  the  order  
of  four  mutants  per  108  cells  as  generally  observed  [14].  Furthermore,  
removal   of   RecA,   a   previously   suggested   key   actor   in   adaptive  
mutations   [15],   displayed   only   a   marginally   negative   effect   on   the  





Figure   4.   Time-­‐‑dependent   trends   in   mutational   mechanisms.   (a)   The  
frequency  of  rpoS  mutations  in  isolated  mutants  is  increasing  with  time.  The  
x-­‐‑axis   shows   days   after   plating.   (b)   Isolated   mutants   show   a   distinct  
mutation  pattern  in  the  crp  gene.  Over  time,  there  is  a  steady  increase  in  8-­‐‑
oxoG  mutations  whereas  the  C-­‐‑deamination  associated  mutations  decrease.    
  
Discussion    
In   the   present   study,   we   sequenced   96   adaptive   mutants   isolated  
during   a   two-­‐‑month   period,   after   having   arisen   from   a   minimally  
perturbed   genetic   background.   To   our   knowledge,   a   similar  
experiment   has   not   been   performed   at   this   time   scale   previously.  
Importantly,   time   was   an   essential   factor   not   only   for   the  
development   of   adaptive   mutation,   but   also   seemingly   for   the  
mutational   mechanism   and   we   show   that   a   highly   dominating  
proportion   of   the   adaptive  mutations   are   8-­‐‑oxo-­‐‑G  modifications   on  
the   transcribed   strand.   This   strongly   supports   the   retromutagenesis  
model   as  a  major  mechanism  behind  adaptive  mutations.  Were   this  
process   generalised   to  multicellular   organisms   it  would   be   a   fertile  
contribution  to  the  initiation  of  cancer  that  parallels  ageing.    
  
Methods    
Because   the   fnr  gene   is  a  homologue  of  crp,  we  used  a  starter   strain  
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ca.   40   kb   deletion   in   the   fnr   region   [16].   The   cyaA   deletion   was  
introduced   with   lambda   Red-­‐‑induced   recombination   [17].   In   pilot  
experiments,  we  had  noticed  that  the  presence  of  a  pTrc99A  plasmid  
(Pharmacia  Biotech)  carrying  the  E.  coli  tig  gene  (PCR  amplified  with  
the   oligonucleotides  
5’CATGCCATGGTGAGGTAACAAGATGCAAGTTTC3’   and  
5‘CGCGGATCCAATTACGCCTGCTGGTTCATC3’   and   cloned   into  
the   NcoI   and   BamHI   restriction   sites)   produced   twice   as   many  
mutants   that   in   absence   of   the   tig  plasmid,   typically   allowing  us   to  
recover  around  200  mutants  in  each  two  months  experiment,  a  figure  
quite   convenient   to   get   significant   observations.   Thus   K12   Mg1655  
(cyaA::cat   delta   fnr,   pTrctig)   is   our   starter   strain.   The   recA   deletion  
from   the   Keio   collections   [18]   was   used   to   prepare   a   P1   lysate   by  
standard  procedures.    
  
For  growth  on  plates  the  lactose-­‐‑free  MacConkey  medium  was  used  
[19]   (Difco   MacConkey   Agar   Base)   supplemented   with   1%  
carbohydrate   (maltose   in   most   experiments)   or   glycerol   and  
chloramphenicol,  5  mg/litre,  ampicillin,  100  mg/litre,  and  1  mM  IPTG.  
For   subsequent   3-­‐‑times   purification   of   papillae,   chloramphenicol,  
ampicillin  and  IPTG  were  omitted  from  the  plates.  To  obtain  isolated  
colonies  on  the  plates,  early  stationary-­‐‑phase  grown  bacteria  from  the  
LB  liquid  culture  (37°C)  were  diluted  in  sterile  water  containing  9  g/l  
sodium  chloride,   to   the  concentration  of  2.5×104  bacteria/ml  and  100  
µμl   of   the   bacterial   suspension   was   spread   onto   MacConkey   plates.  
The   plates   were   subsequently   placed   in   plastic   boxes   containing  
beakers  with  water   to   ensure   constant   humidity   and  placed   for   the  
duration   of   the   experiment   in   an   incubator   at   37°C.   To   test   for  
mutator  phenotypes,  rifampicin  agar  plates  were  prepared  using  the  
LB   medium   agar   supplemented   with   100   mg/liter   rifampicin  
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prepared   in   methanol.   At   all   times   the   plates   were   wrapped   in  
aluminium  foil  for  protection  from  light.    
  
The  genomic  libraries  were  generated  using  the  TruSeq®Nano  DNA  
LT  Sample  Preparation  Kit   (Illumina  Inc.).  498   independent  papillae  
were   selected   for   amplification   of   the   crp   region   by   direct   colony  
PCR.  The  PCR  reaction  was  made  using  Red-­‐‑Taq  polymerase  (Sigma-­‐‑
Aldrich)   according   to   the  manufacturer'ʹs   instructions   (hybridisation  
at   55°C)   with   the   following   primers:   forward   primer  
5’TTTCGGCAATCCAGAGACAGC3’   and   reverse   primer  
5’AACATAGCACCAGCGTTTGTCG3’.   The   amplified   crp   regions  
were   sequenced   by   Sanger   method   with   two   primers:   forward  
5’TTATCTGGCTCTGGAGAAAGC3’   and   reverse   primer  
5’TCGAAGTGCATAGTTGATATCGG3’.    
  
     
	   75	  
References    
  
1. Bridges,  B.  A.  mutY  ‘directs’  mutation?  Nature  375,  741  (1995).    
2. Doetsch,   P.   W.   Translesion   synthesis   by   RNA   polymerases:  
occurrence   and   biological   implications   for   transcriptional  
mutagenesis.  Mutat.  Res.  510,  131–  140  (2002).    
3. Morreall,  J.  et  al.  Evidence  for  retromutagenesis  as  a  mechanism  for  
adaptive   mutation   in   Escherichia   coli.   PLoS   Genet   11,   e1005477  
(2015).    
4. You,   C.   et   al.  Coordination   of   bacterial   proteome  with  metabolism  
by  cyclic  AMP  signalling.  Nature  500,  301–306  (2013).    
5. Sabourin,  D.  &  Beckwith,  J.  Deletion  of  the  Escherichia  coli  crp  gene.  
J  Bacteriol  122,  338–340  (1975).    
6. Saxer,   G.   et   al.   Mutations   in   global   regulators   lead   to   metabolic  
selection   during   adaptation   to   complex   environments.   PLoS   Genet  
10,  e1004872  (2014).    
7. Bleibtreu,   A.   et   al.   The   rpoS   gene   is   predominantly   inactivated  
during   laboratory   storage   and   undergoes   source-­‐‑sink   evolution   in  
Escherichia  coli  species.  J  Bacteriol  196,  4276–4284  (2014).    
8. Nystrom,  T.  The   free-­‐‑radical  hypothesis  of   aging  goes  prokaryotic.  
Cell  Mol  Life  Sci  60,  1333–1341  (2003).    
9. Hall,   B.   G.   Spectrum   of   mutations   that   occur   under   selective   and  
non-­‐‑selective  conditions  in  E.  coli.  Genetica  84,  73–76  (1991).    
10. Bridges,  B.  A.  Mutation  in  resting  cells:  the  role  of  endogenous  DNA  
damage.  Cancer  Surv  28,  155–167  (1996).    
11. Brégeon,  D.,  Doddridge,  Z.  a.,  You,  H.  J.,  Weiss,  B.  &  Doetsch,  P.  W.  
Transcriptional  mutagenesis  induced  by  uracil  and  8-­‐‑oxoguanine  in  
Escherichia  coli.  Mol.  Cell  12,  959–970  (2003).    
12. Davis,  B.  D.  Transcriptional  bias:  a  non-­‐‑Lamarckian  mechanism  for  
substrate-­‐‑  induced  mutations.  Proc  Natl  Acad  Sci  U  S  A  86,  5005–5009  
(1989).    
13. Maisnier-­‐‑Patin,   S.   &   Roth,   J.   R.   The   origin   of   mutants   under  
selection:   How   natural   selection   mimics   mutability   (adaptive  
mutation).  Microb.  Evol.  (2014).    
	  76	  
14. Jin,  D.  J.  &  Gross,  C.  a.  Mapping  and  sequencing  of  mutations  in  the  
Escherichia  coli  rpoB  gene  that  lead  to  rifampicin  resistance.  J.  Mol.  
Biol.  202,  45–58  (1988).    
15. Taddei,  F.,  Halliday,  J.  A.,  Matic,   I.  &  Radman,  M.  Genetic  analysis  
of  mutagenesis  in  aging  Escherichia  coli  colonies.  Mol  Gen  Genet  256,  
277–281  (1997).    
16. Soupene,   E.   et   al.   Physiological   studies   of   Escherichia   coli   strain  
MG1655:   growth   defects   and   apparent   cross-­‐‑regulation   of   gene  
expression.  J  Bacteriol  185,  5611–5626  (2003).    
17. Datta,   S.,   Costantino,   N.   &   Court,   D.   L.   A   set   of   recombineering  
plasmids  for  gram-­‐‑negative  bacteria.  Gene  379,  109–115  (2006).    
18. Baba,  T.  et  al.  Construction  of  Escherichia  coli  K-­‐‑12  in-­‐‑frame,  single-­‐‑
gene   knockout   mutants:   the   Keio   collection.  Mol   Syst   Biol   2,   2006  
0008  (2006).    
19. MacConkey,  A.   Lactose-­‐‑fermenting   bacteria   in   feces.   J  Hyg  5,  333–
378  (1905).    
  
     
	   77	  
Acknowledgements    
This  work  was   supported   by   The  Novo  Nordisk   Foundation   and   a  
PhD  grant  from  the  People  Programme  (Marie  Curie  Actions)  of  the  
European   Union’s   Seventh   Framework   Programme   [FP7-­‐‑People-­‐‑
2012-­‐‑ITN],   under   grant   agreement   No.   317058,   “BACTORY”.   We  
thank   Ida   Lauritsen   and   Emil   Christian   Fischer   for   technical  
assistance,   and  Anna  Koza   and   Ida   Bonde   for   their   assistance  with  
NGS.    
  
Author  contributions    
AD  and  MHHN  designed  the  experiments,  supervised  the  work  and  
wrote   the   manuscript.   AZ   and   SW   carried   out   the   experiments,  
contributed  to  the  manuscript  and  prepared  the  figures.    
  
Competing  financial  interests  statement    
The  authors  have  no  competing  financial  interests.    
     
	  78	  
     
	   79	  
Supplementary  material  to  Paper  I  
     
	  80	  
Supplementary  methods    
Escherichia   coli   K12   remains   the   best-­‐‑known   living   species.   The  
genomes   of   several   laboratory   strains   have   been   sequenced,   and   it  
has  been  observed   that   there   is   significant  variation  between  strains  
[1].  Two  major   sources  of   laboratory  strains  have  been   investigated,  
MG1655,   by   Fred   Blattner   and   co-­‐‑workers   [2],   and   W3110   by  
Hirotada   Mori   and   co-­‐‑workers   (origin   of   the   Keio   collection   [3]).  
Strain  MG1655   seems   to  be   the   closest   isolate   from   the  original  K12  
isolate,  which  has  now  been  lost.  Beside  a  range  of  variants  present  in  
different   laboratories,   an   initial   isolate   of  MG1655   deposited   at   the  
Escherichia  coli  Genetic  Stock  Center  (ECGSC)  was  shown  to  harbour  
a  ca.  40  kb  deletion  in  the  fnr  region  [1].  For  our  experimental  chassis  
we  wished  to  construct  a  cyaA  deletion  strain,  preventing  cells   from  
synthesising  cyclic  AMP.  We  expected  that  among  adaptive  mutants  
we   might   obtain   crp   derivatives   of   the   crp   gene   (crp*),   coding   for  
variants   of   the   Cyclic   AMP   Receptor   Protein   (CRP),   as   previously  
obtained  by  Sabourin  and  Beckwith   [4].  Because   the  FNR  protein   is  
strongly  similar  to  CRP  we  were  concerned  that  we  might  stumble  on  
interference  between  crp  and   fnr   that  would  have  been  confounding  
our  observations.  For   this   reason  we  decided   to  use  as  a  chassis   the  
strain  previously  identified  as  MG1655  at  the  ECGSC  [1],  a  strain  that  
was   used   with   success   recently   in   experiments   exploring   the  
swarming   behaviour   of   E.   coli   [5].   In   preliminary   experiments   we  
indeed  found  that  papillae  were  produced  on  our  selective  medium  
(MacConkey   plates   supplemented   with   maltose   as   the   superfluous  
carbon   source).   However,   we   wished   to   make   the   most   of   our  
experimental   set-­‐‑up,  while  we  had  noticed   that  many  E.  coli   strains,  
when   streaked  on  plates   for   conservation  and   then   reused,  had   lost  
the  activity  of  their  rpoS  gene  [6–8].  RpoS  has  an  important  role  under  
stationary   phase   conditions,   in   particular   because   it   controls  
synthesis   of   a   protein   that   should   have   an   important   role   in   our  
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experiment,  the  ribosome  trigger  factor  (TIG),  involved  in  the  folding  
of   proteins   in   statu   nascendi   [9].   We   therefore   introduced   in   our  
chassis,  beside  a  replacement  of  the  cyaA  gene  by  a  chloramphenicol  
cassette,   a   plasmid   coding   for   tig.   We   noticed   that   the   number   of  
papillae   produced   under   such   conditions   was   about   twice   that   in  
absence  of  the  tig  plasmid,  allowing  us  to  recover  some  100  papillae  
or  so  in  each  two  months  experiment,  a  figure  quite  convenient  to  get  
significant  observations.  Our   chassis   is   therefore   strain  AMBEC7001  
(cyaA::cat  Δfnr,  pTrctig).    
  
In  our  set-­‐‑up  we  expected  that  crp*  mutations  would  display  a  GASP  
phenotype.  However,   the   experiments   by   Jon  Beckwith'ʹs   laboratory  
[4]  showed  that  under  exponential  growth  constitutively  positive  crp  
mutations  were  very  rare  (of  the  order  of  1  in  109  cells).  Mutagenesis  
would   considerably   increase   the   amount   of   such  mutations.  Hence,  
inactivating  antimutator  genes  would  result  in  an  overall  increase  of  
mutations,  without   allowing  much   insight   into   the  process.   For   this  
reason  we  were  careful  to  avoid  bacterial  chasses  that  carry  mutator  
genes.  In  particular,  the  MutM  and  MutY  proteins  correct  mutations  
induced  by   the  presence  of   8-­‐‑oxoguanine   [10,11];  MutM  removes  8-­‐‑
oxoG  paired  with  C  in  DNA  whereas  MutY  removes  A  paired  with  8-­‐‑
oxoG   in   syn   conformation   in   the   double   helix.   As   an   essential  
requirement,   the   mutM   and   mutY   genes   are   undamaged   in   our  
chassis.  Indeed,  our  preliminary  experiments  showed  that  the  strains  
submitted  to  ageing  in  stationary  phase  did  not  display  an  increase  in  
rifampicin  resistant  mutants  (rpoB).  
  
The  genomic  libraries  were  generated  using  the  TruSeq®Nano  DNA  
LT  Sample  Preparation  Kit  (Illumina  Inc.).  Briefly,  100  ng  of  genomic  
DNA   was   diluted   in   52.5   µμl   TE   buffer   and   fragmented   in   Covaris  
Crimp  Cap  microtubes   on   a   Covaris   E220   ultrasonicator   (Woburn).  
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According   to   Illumina’s   recommendations   for   a   350-­‐‑bp   average  
fragment   size,   the   settings   used   were   5%   duty   factor,   175  W   peak  
incident  power,  200  cycles/burst,  and  50-­‐‑s  duration  under  frequency  
sweeping   mode   at   5.5   to   6°C.   The   ends   of   fragmented   DNA   were  
repaired  by  T4  DNA  polymerase,  Klenow  DNA  polymerase,  and  T4  
polynucleotide  kinase.  The  Klenow  exo  minus  enzyme  was  then  used  
to  tail  an  'ʹA'ʹ  base  to  the  3’  end  of  the  DNA  fragments.  After  ligation  
of   adapters,   DNA   fragments   ranging   from   300   -­‐‑   400   bp   were  
recovered   by   bead   purification.   Finally,   the   adapter-­‐‑modified  DNA  
fragments  were  enriched  by  3  cycles  of  PCR.  The  final  concentration  
of  each  library  was  measured  by  Qubit®  2.0  Fluorometer  and  Qubit  
DNA  Broad  range  assay  (Life  Technologies).  Average  dsDNA  library  
sizes  were  determined  using  the  Agilent  DNA  7500  kit  on  an  Agilent  
2100   Bioanalyzer.   Libraries  were   normalised   and   pooled   in   10  mM  
Tris-­‐‑HCl,  pH  8.0,  0.05%  Tween  20  to  a   final  concentration  of  10  nM.  
10   pm   pools   of   20   libraries   in   600   µμl   ice-­‐‑cold   HT1   buffer   were  
denatured   in  0.2N  NaOH,   loaded  onto  the  flow  cell  provided  in   the  
MiSeq   Reagent   kit   v2   and   sequenced   on   a   MiSeq   (Illumina   Inc.)  
platform,  with  a  paired-­‐‑end  protocol  and  read  lengths  of  151  nt.  The  
Illumina   sequencing   data   was   quality-­‐‑trimmed   using   the  
Trimmomatic   tool   (version   0.32)   [12]   with   the   settings   CROP:145  
HEADCROP:15   SLIDINGWINDOW:4:15   MINLEN:30.   The   cleaned  
data  was  used  as   input   for  variant   calling  using   the  breseq  pipeline  
(version  0.26.0)  [13]  with  –j  4  and  –b  20  as  the  only  changes  to  default  
settings.   The   reference   strain   for   this   analysis   was   Escherichia   coli  
MG1655  with  the  accession  number  NC_000913.3.  
  
Supplementary  discussion    
Besides   genes   relevant   to   the   process   of   carbon   source   usage,   the  
sequencing   of   96   papillae   genomes   revealed   several   hotspots   and  
several  regions  of  instability  (see  main  text).  The  latter  are  all  related  
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to  mobile  elements.  In  particular  the  icd  gene  is  the  place  of  prophage  
e14  attachment  site  [14],  and  it  appears  from  our  data  that  this  region  
remains   unstable   in   our   experimental   conditions.   A   similar  
observation   was   made   when   investigators   explored   the   GASP  
phenotype  [15].  In  fact,  the  whole  region  is  unstable  as  witnessed  by  
mutations  in  genes  ymfE,  ymfI  and  ymfJ  (see  Supplementary  Table  2).  
In  addition  to  mutations   in  crp,  rpoS  and  malT,  gene  cmk,   coding  for  
Cytidylate  kinase,  seems  to  be  a  mutational  hotspot.  In  the  cmk  rpsA  
operon   [16],   the   latter   gene   coding   for   ribosomal   protein   S1   in  
Proteobacteria  and  an  mRNA  binding  protein  in  Firmicutes,  is  widely  
conserved   in   Bacteria   [17].   Cytidylate   kinase   is   critical   for   the  
production   of   CDP,   the   immediate   precursor   of   dCDP   that   is   an  
absolute  requirement  for  the  presence  of  cytosine  in  DNA  [18],  and  a  
major   source   of   thymine   as   well   [19].   The   metabolism   during  
stationary   phase   may   require   maintenance   of   a   stable   CTP   pool,  
asking   for   the   presence   of   both   CMK   and   nucleoside  
diphosphokinase,   but   the   reason   for   an   increased  mutation  number  
in  the  cmk  gene  is  unknown.  However,  an  unexpected  phenotype  of  
the   cmk   gene   revealed   that   it   was   involved   in   the   control   of  
chromosome   maintenance   (cmk   was   originally   named   mssA,  
suppressor   of   a   cold   sensitive   growth   of   mutants   in   the   uridylate  
kinase   gene   [20]),   suggesting   that   it  may   belong   to   some   important  
role  in  this  domain.    
  
The  present  work  resulted  in  the  selection  of  a  very  large  number  of  
CRP  variants.   It  seems  that  despite  the  number  of  mutants  explored  
(ca.   600),   there   is   still   room   for   further   mutants   to   appear.   The  
phenotype   of   the   papillae   was   assayed   on   MacConkey   medium  
supplemented  with  maltose,  mannitol,  glycerol  or  sorbitol,  as  well  as  
on  EMB  maltose  plates  (Supplementary  Table  1).  The  corresponding  
phenotypes   are   driven   by   the   sequence   of   the   CRP   protein,   but  
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mutations   elsewhere   in   the   genome   can   also   impact   the   phenotype  
(see   for   example   in   Supplementary   Table   1   papilla   1   compared   to  
papilla   3).   The   present   work   could   be   a   first   step   in   the  
understanding   of   functional   networks   directing   carbon   source  
utilisation.  Remarkably,   previous  knowledge  was   far   from   covering  
the   whole   set   of   what   we   observed.   This   highlights   a   rarely  
underlined   process   of   evolution   that   can   be   explored   using  
experiments  similar  to  the  one  presented  in  this  article.  
  
The   two  maltose-­‐‑positive   clones   that   carried   a   wild-­‐‑type   crp   had   a  
weak   positive   phenotype   and   a   mutation   in   rpoS,   besides   other  
mutations.  These  mutants,  in  contrast  to  the  mutants  in  the  crp  gene,  
did   not   grow   on  minimal   plates   supplemented  with  maltose.   They  
may  have  uncovered  pathways  allowing  for  growth  on  components  
of  the  rich  MacConkey  medium  that  the  starter  strain  could  not  use.    
  
Finally,  noting  that  we  did  not  find  any  hint  of  RecA  involvement  in  
the  genomes  we  sequenced,  and  to  validate  a  possible  role  of  RecA  in  
adaptive  mutation  as  previously  suggested  [21],  we  introduced  a  recA  
mutation  in  our  root  strain  and  monitored  the  appearance  of  positive  
papillae.   Interestingly,   while,   overall,   there   does   not   seem   to   be   a  
large  decrease  of   the  total  number  of  papillae   in  a  recA-­‐‑background,  
the   time   course   of   their   appearance   is   considerably   retarded   as  
compared   to   the   situation   observed   in   the   cyaA-­‐‑   background  
(Supplementary   Figure   1).   Indeed,   it   takes   a   long   time   for   the   first  
papillae   to  appear   in   the   recA-­‐‑  background,  but   their  number  keeps  
increasing,   for   up   to   two   months,   with   the   total   number   observed  
similar  to  that  found  in  the  cyaA-­‐‑  reference  strain.  In  our  context,  recA  
mutants   are   growing   more   slowly   than   their   parent   counterpart.  
Whether   this   growth   rate   can   account   for   the   delay   in   papillae  
appearance  warrants  further  studies.  
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Supplementary  figure  
Supplementary  Figure  1.  Time  course  of  papillae  formation  in  a  cyaA-­‐‑  
strain  and  cyaA  recA  double  mutant.  (a)  Papillae  formation  is  delayed  in  
the  cyaA  recA  (orange  diamonds)  mutant  compared  to  the  cyaA  deficient  
reference  strain  (light  orange  squares).  In  the  cyaA  mutant  the  first  papillae  
are  appearing  on  the  5th  day  of  experiment  and  terminating  over  the  32nd  
day,  while  in  the  cyaA  recA  double  mutant  the  first  papillae  are  appearing  on  
the  10th  day  and  keep  appearing  on  the  52nd  day  after  the  inoculation.  
Papillae  are  represented  as  accumulated  total  number  of  occurrences.  (b)  An  
example  of  a  typical  plate  with  the  papillae  after  6  days.    




Supplementary Figure 1. Time course of papillae formation in a cyaA- strain and cyaA 
recA doubl  muta t. (a) Papill e formation is delayed in the cyaA recA (orange diamonds) 
mutant compared to the cyaA deficient reference strain (light orange squares). In the cyaA 
mutant the first papillae are appearing on the 5th day of experiment and terminating over the 
32nd day, while in the cyaA r cA double utant the first papillae are appearing on th  10th day 
and keep appearing on the 52nd day after the inoculation. Papillae are represented as 
accumulated total number of occurrences. (b) An example of a typical plate with the papillae 
after 6 days. 
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Supplementary  table  1.  
Phenotypic  characterisation  of  the  96  isolated  mutants.  The  
phenotypes  of  the  papillae  were  assayed  on  MacConkey  medium  
supplemented  with  maltose,  mannitol,  glycerol  or  sorbitol,  as  well  as  
on  EMB  maltose  plates.  On  MacConkey  plates,  colonies  can  be  either  
red,  pink  or  white,  and  in  some  cases  red  at  the  centre  but  white  
around  ("ʺfisheye"ʺ  phenotype).  On  EMB,  colonies  can  be  very  dark  
(black),  often  with  a  remarkable  green  shine  (gold  green),  purple,  or  
in  some  cases  white.  
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Supplementary  table  2.  
Mutations  in  the  96  genomes  sequenced  using  NGS.  The  mutation  
sites  observed  in  the  96  mutants  are  described.  The  origin  of  the  
mutation  is  colour  coded:  G-­‐‑>T  transversions  are  in  blue  while  C-­‐‑>A  
transversions  are  in  green;  C-­‐‑>T  transitions  are  in  yellow  and  G-­‐‑>A  
transitions  are  in  pink.  Hotspot  regions  are  coloured  light  grey  (and  
the  crp  region  is  in  orange).    
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Abstract    
Background:  Bacterial   surface   display   is   an   attractive   technique   for  
the  production  of  cell-­‐‑anchored,  functional  proteins  and  engineering  
of   whole-­‐‑cell   catalysts.   Although   various   outer   membrane   proteins  
have   been   used   for   surface   display,   an   easy   and   versatile   high-­‐‑
throughput-­‐‑compatible   assay   for   evaluating  and  developing   surface  
display  systems  is  missing.    
Results:  Using  a  single  domain  antibody  (also  called  nanobody)  with  
high   affinity   for  GFP,  we   constructed   a   system   that   allows   for   fast,  
fluorescence-­‐‑based   detection   of   displayed   proteins.   The   outer  
membrane   hybrid   protein   LppOmpA   and   the   autotransporter   C-­‐‑
IgAP   exposed   the   nanobody   on   the   surface   of   Escherichia   coli  with  
very   different   efficiency.   Both   anchors  were   capable   of   functionally  
displaying   the   enzyme  Chitinase  A   as   a   fusion  with   the   nanobody,  
and   this   considerably   increased   expression   levels   compared   to  
displaying   the  nanobody  alone.  We  used   flow  cytometry   to  analyse  
display   capability   on   single-­‐‑cell   versus   population   level   and   found  
that   the   signal   peptide   of   the   anchor   has   great   effect   on   display  
efficiency.    
Conclusions:  We  have  developed  an   inexpensive  and  easy  read-­‐‑out  
assay  for  surface  display  using  nanobody:GFP  interactions.  The  assay  
is  compatible  with  the  most  common  fluorescence  detection  methods,  
including   multi-­‐‑well   plate   whole-­‐‑cell   fluorescence   detection,   SDS-­‐‑
PAGE   in-­‐‑gel   fluorescence,   microscopy   and   flow   cytometry.   We  
anticipate   that   the  platform  will   facilitate   future   in-­‐‑depth  studies  on  
the  mechanism  of  protein   transport   to   the   surface   of   living   cells,   as  
well  as  the  optimisation  of  applications  in  industrial  biotech.    
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Background    
Cell   factories   are   a   promising   alternative   to   the   problematic   fossil  
fuel-­‐‑based   technologies   currently  employed   in   industry   [1].  Cellular  
surface  display  of  proteins  is  an  attractive  way  to  engineer  whole-­‐‑cell  
catalysts,   thereby   reducing   time,   cost   and   effort   related   to   enzyme  
purification  and  one-­‐‑time  use  of  enzyme  batches.  Displaying  proteins  
on   the   cell   surface   has   the   evident   benefits   of   omitting   any  need   to  
transport   substrate   or  product   across   the   cell  wall,   and  may   reduce  
toxicity   effects   due   to   the   extracellular   location   of   pathway  
components,   substrates   and   products.   The   first   successful   cases   of  
surface  display  were  reported  more  than  three  decades  ago  [2,  3]  but  
as   pointed   out   by   Schüürmann   et   al.,   industrial   development   of  
whole-­‐‑cell   catalysts   is   lagging   behind   [4].   Surface   display   has   been  
successfully  carried  out  on  several  platforms  such  as  yeast  [5],  phage  
[6]  and  bacteria  [4]  with  several  different  cargos  (typically  antibodies  
or   enzymes).   Nevertheless,   detailed   fundamental   understanding   of  
the  molecular  mechanisms  underlying  surface  display  is  lacking,  thus  
complicating  rational  design  [4,  7–9].  Furthermore,   the  development  
of   display   systems   suffers   from   a   lack   of   simple   and  wide-­‐‑ranging  
assay   methods,   which   would   allow   for   easy   detection   and  
optimisation.  Recently,  an  increasing  number  of  studies  have  shown  
the  use  of   fluorescently   labelled  antibodies  as  a  non-­‐‑generic  method  
for  visualising  surface  displayed  proteins,  and  enabling  not  only  their  
detection  but  also  flow  cytometric  analysis  and  microscopy  [10–12].    
  
Several  different  membrane  anchors  have  been  explored  for  bacterial  
surface  display;  two  of  the  main  ones  are  autotransporters  and  outer  
membrane  proteins   from  gram-­‐‑negative  bacteria   (for  review  see  e.g.  
[4,   13]).   Autotransporters   are   typically   involved   in   virulence   and  
have  been  extensively  explored  for  bacterial  surface  display   [14–16].  
Autotransporter  proteins  consist  of  an  N-­‐‑terminal  signal  peptide  that  
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directs   the  polypeptide   through   the  plasma  membrane,   a  passenger  
domain   that   typically   encodes   a   virulence   factor,   and   a   C-­‐‑terminal  
translocation  unit  that  enables  the  transport  of  the  passenger  domain  
across   the   outer   membrane   (fig   1a)   [9].   While   the   transport   of   the  
passenger  domain  has  given  autotransporters   their  name,   the  whole  
protein   as   such   is   dependent   on   the   barrel   assembly   machinery  
(BAM)   complex   to   reach   the   cell   surface   [17,   18].   The   C-­‐‑terminal  
translocation   unit   of   the   Neisseria   gonorrhoeae   autotransporter   IgA  
protease   (C-­‐‑IgAP)  has  been   extensively   characterised   in   terms  of   its  
mechanism   of   protein   secretion   as   well   as   employed   for   surface  
display   in   E.   coli   [19,   20].   Native   E.   coli   outer   membrane   proteins  
constitute  a  different  class  of  surface  display  anchors.  The  LppOmpA  
fusion,   consisting   of   the   Lpp   signal   peptide   followed   by   five  
transmembrane   segments   of   Outer   membrane   protein   A,   has   been  
successfully   used   to   display   enzymes   such   as   hydrolases   on   the  
surface  of  E.  coli  (fig  1b)  [11,  21].    
  
Figure   1.   Illustrations   of   the   nanobody:GFP   complex   and   the   outer  
membrane   anchors.  A,  B.  Schematic   illustration   of   the   nanobody   (orange)  
A)  as  passenger  of  the  autotransporter  C-­‐‑IgAP  construct  and  B)  fused  to  the  
outer   membrane   protein   OmpA.   C.   Crystal   structure   of   the   enhancer  
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Surface  display  of  proteins  has  many  parallels  to  bacterial  membrane  
protein   production,   which   is   an   inherently   difficult   process,  
dependent   on   proper   balancing   of   the   transport   machineries   and  
with   optimal   process   conditions   varying   for   different   proteins   [22–
24].  The  detection  and  optimisation  of  membrane  protein  production  
was   dramatically   simplified   by   the   development   of   a   GFP-­‐‑fusion  
platform   that   enabled   real-­‐‑time   monitoring,   quantification   and   fast  
analysis   of   protein   integrity   and  membrane   association   [25,   26].   As  
pointed  out  by  Sun  et  al.,  displaying  GFP  on  the  surface  of  cells  could  
similarly  be  used  to  assess  surface  display  levels  [10].  This  approach,  
however,  comes  with  a  major  drawback:  cells  producing  folded  GFP  
would   be   fluorescent   regardless   of   whether   the   GFP   protein   was  
actually   displayed   on   the   cell   surface   or   not,   i.e.   if   the   protein  
remained   in   the   cytoplasm   or   periplasm.   Only   with   methods   like  
advanced   microscopy   or   complicated   separation   of   compartments  
could   one   differentiate   between   surface   localised   and  
cyto/periplasmic   GFP   signal,   and   no   conclusions   about   display  
efficiency   could   be   drawn   from   a   simple   readout   like   whole-­‐‑cell  
fluorescence.   We   therefore   set   out   to   develop   a   fluorescence-­‐‑based  
method  for  surface  display  evaluation  using  an  alternative  approach,  
making   use   of   a   single-­‐‑chain   antibody   molecule   known   as   a  
nanobody.    
  
Nanobodies   (NB),   found   in   camelids   and   sharks,   are   single  domain  
antibodies   that   carry   out   the   same   function   as   full-­‐‑size   antibodies  
whilst   consisting   of   only   a   variable   heavy   fragment   [27,   28].   The  
small   size   of   nanobodies  makes   them   convenient   protein   tags,   and  
the   absence   of   essential   disulphide   bonds   makes   them   easy   to  
produce  in  E.  coli  [29,  30].  Kirchhofer  et  al.  developed  nanobodies  that  
bind   GFP  with   high   specificity   and   affinity   in   a   stable   complex;   in  
fact,   the   complex   is   stable   enough   to   sustain  denaturing  SDS-­‐‑PAGE  
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analysis   (fig   1c)   [31,   32].   Here,   we   have   constructed   a   system   for  
fluorescence-­‐‑   based  detection   of   surface   display   by   fusing   the  GFP-­‐‑
nanobody   to   different   outer  membrane   anchors   and   visualising   the  
displayed  protein  by  adding  purified  GFP  to  whole  cells.    
  
Results    
Construction  of  nanobody  modules  for  surface  display    
GFP   as   reporter   for   surface   displayed   proteins   is   problematic,  
because   it   is   difficult   to   differentiate   between   intracellular   and  
surface   displayed   protein.   Therefore,   we   used   a   complementary  
approach   where   the   surface   displayed   protein   is   fused   to   a   GFP-­‐‑
nanobody  and  subsequently  detected  using  purified  GFP  added  from  
the  outside  (fig  2a).    
  
Two   different   display   modules   containing   the   nanobody   were  
constructed,  using  the  previously  described  GFP-­‐‑enhancer-­‐‑nanobody  
sequence   [31].   As   anchors,   we   chose   two   commonly   used   outer  
membrane   proteins:  We   designed   one   display   vector   containing   an  
Outer   membrane   protein   A   (OmpA)   domain,   and   one   vector  
containing  an  autotransporter  domain,   in  both  cases  using  the  high-­‐‑
copy   plasmid   pKS1,   herein   called   pK   [33].   The   outer   membrane  
protein-­‐‑based   vector   pK:LppOmpA-­‐‑NB   contains   the   N-­‐‑terminal  
signal  peptide  of   the  E.  coli   lpp  gene   (residues  M1   to  Q29),   followed  
by   residues   N66   to   G180   of   OmpA   (forming   five   beta-­‐‑strand  
transmembrane   segments)   and   a   C-­‐‑terminally-­‐‑fused   nanobody  
sequence   (fig   2b).   An   alternative   vector,   pK:pelB-­‐‑NB-­‐‑C-­‐‑IgAP,   was  
constructed   by   fusing   the   nanobody   in-­‐‑between   the   pelB   signal  
peptide   and   the   C-­‐‑terminal   domain   of   the   N.   gonorrhoeae  
autotransporter  IgA  protease  (C-­‐‑  IgAP)  (fig  2b).  In  both  cases,  protein  
production   is  under   the  control  of   the  rhamnose-­‐‑inducible  rhaPBAD  
promoter.    
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Figure   2. Characterisation   of   the  NB:GFP  platform.  A.   Illustration   of   the  
principal  difference  between  displaying  GFP  and  displaying   the  nanobody  
on   the   surface   of   the   cell.   GFP   gives   the   cell   a   fluorescent   glow   whether  
produced   intracellularly   (ic)   or   on   the   surface   (surf).   In   contrast,   the   only  
way  a  cell  producing  the  nanobody  can  be  fluorescent  is  if  the  nanobody  is  
displayed   on   the   surface   and   accessible   to   extracellular   GFP.   B.   Protein  
schemes   for   the   OmpA   and   autotransporter   constructs.   An   N-­‐‑terminal  
signal  sequence  (lppss  and  pelBss)  precedes  the  OmpA  anchor  followed  by  
the   nanobody,   or   the   nanobody   followed   by   the   C-­‐‑IgAP   anchor,  
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respectively.  C.  Workflow  of  GFP  assay:   cells  producing   the  nanobody  are  
incubated  with  free  GFP;  unbound  GFP  is  washed  off  and  the  fluorescence  
signal   from  GFP  bound   to  nanobody  on   cells   is   assayed  using  SDS-­‐‑PAGE,  
fluorescence   measurements   and   microscopy.   D.   In-­‐‑gel   fluorescence   of  
purified   GFP;   purified   GFP   mixed   with   purified   NB;   NB;   whole   cells  
displaying  OmpA-­‐‑NB  or  NB-­‐‑C-­‐‑IgAP  with   and  without  GFP  and  with   and  
without   proteinase   K   treatment.   The   same   amount   of   cells   was   loaded   in  
each   lane   for  whole   cell   samples.  E.  Whole-­‐‑cell   fluorescence  measurement  
with   and   without   rhamnose   induction.   Values   are   averages   of   three  
biological   replicates   and   bars   show   standard   error.   F.   Bright   field   and  
fluorescence  microscopy  images  of  OmpA-­‐‑NB  displayed  on  E.  coli  cells,  with  
and   without   rhamnose   induction.   G.   Flow   cytometry   profiles   of  
pK:LppOmpA-­‐‑NB  and  pK:NB-­‐‑C-­‐‑IgAP  with   induction   (green)   and  without  
induction   (red).   Percentage   numbers   show   the   fraction   of   cells   that   are  
fluorescent.    
Lppss:   lpp   signal   sequence;   pelBss:   pelB   signal   sequence;   OmpA:   Outer  
membrane  protein  A;  NB:  nanobody;  C-­‐‑IgAP:  C-­‐‑terminal  of  IgA  protease.    
  
  
Functional,   surface   displayed   nanobody   is   robustly   assayed  
using  GFP    
pK:LppOmpA-­‐‑NB  and  pK:NB-­‐‑C-­‐‑IgAP  were   transformed   into  E.   coli  
BL21(DE3)  and  protein  production  was  induced  in  liquid  culture  by  
the   addition   of   5  mM   rhamnose.   After   3   h   of   induction,   cells  were  
harvested,   resuspended   in   buffer   and   incubated  with   purified   GFP  
for   20   min   at   30°C.   Cells   were   harvested   and   washed   twice   with  
buffer  to  remove  any  unbound  GFP;  the  repeated  centrifugation  steps  
also   ensured   that   only  whole   cells   were   assayed.   The  washed   cells  
were  then  subjected  to  (1)  plate  reader  fluorescence  measurement,  (2)  
SDS-­‐‑PAGE   and   in-­‐‑gel   fluorescence   analysis,   (3)   flow   cytometry  
analysis   and   (4)   fluorescence   microscopy   (fig   2c).   In   all   cases   we  
could   detect   a   fluorescence   signal,   showing   the   versatility   of   the  
nanobody:GFP  platform  (fig  2d-­‐‑g).    
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Both  the  autotransporter  C-­‐‑IgAP  and  LppOmpA  anchors  successfully  
displayed  the  nanobody,  as  confirmed  by  in-­‐‑gel  fluorescence  of  OD-­‐‑
normalised   whole-­‐‑cell   samples   after   incubation   with   GFP   (fig   2d).  
The   very   fact   that   cells   are   fluorescing   shows   that   the   nanobody   is  
accessible   from   the   outside   of   the   cell,   and   surface   localisation   is  
further  confirmed  by  Proteinase  K  assay,  removing  all  signal  (fig  2d).  
The  GFP  signal   is   confined   to  bands  corresponding   to  a   complex  of  
GFP   bound   to   the   NB   construct   (theoretical   sizes   55   and   85   kDa,  
respectively)   and  none   of   the   fluorescence   appear   to   originate   from  
free  GFP  (27  kDa,  fig  2d).  Whole  cell  fluorescence  was  measured  in  a  
plate  reader  and  used  to  evaluate  and  quantify  display  ability  of  the  
entire   bacterial   population   (fig   2e).   Induced   cultures   were   highly  
fluorescent   compared   to   uninduced   cultures,   and   the   cultures  
containing  the  LppOmpA  anchor  showed  approximately  three  times  
higher   fluorescence   than   the  C-­‐‑IgAP  cultures.  Nanobody-­‐‑displaying  
cells  were  also  visualised  using  fluorescence  microscopy:  uninduced  
cells   incubated   with   GFP   and   then   washed   prior   to   microscopy  
showed   no   fluorescence   signal,   while   induced   cells   were   strongly  
fluorescent   (fig   2f).   Single   cell   display   behaviour   was   analysed   by  
flow  cytometry,  which  revealed  that  a  fraction  of  the  cells  (22.5%  for  
LppOmpA  and  15.3%  for  C-­‐‑IgAP)  were  responsible   for   the  majority  
of   the   fluorescence   (fig   2g).   Also,   the   top   LppOmpA   expressers  
reached  a  5-­‐‑fold  higher  fluorescence  value  than  the  corresponding  C-­‐‑
IgAP   cells.   C-­‐‑IgAP   producing   cells   were   much   more   negatively  
affected   by   induction   than   LppOmpA   cells;   OD   dropped   by   70%  
when   inducing   NB-­‐‑C-­‐‑IgAP,   and   this   was   not   affected   by   varying  
inducer   concentration   (Additional   file   1:   Fig   S1).   In   contrast,   the  
density   of   LppOmpA   cultures   decreased   gradually   and   less  
dramatically  upon   induction   (Additional   file   1:  Fig  S1).  Background  
fluorescence   from  the  added  GFP  was  essentially  absent,  as  seen  by  
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whole   cell   fluorescence   for   uninduced   cells,   in-­‐‑gel   fluorescence,  
microscopy,  and  flow  cytometry  (fig  2e-­‐‑g).  The  detection  system  was  
functional   and   robust   in   both   small   and   large   format,   with   96-­‐‑well  
format  allowing  high-­‐‑throughput  analyses.    
  
Displaying   a   functional   enzyme   as  GFP-­‐‑detectable   nanobody  
fusions    
The   application   of   the   nanobody   platform   was   further   tested   by  
making   sandwich   fusions   to   the   Chitinase   A   enzyme   from   Serratia  
marcescens  (courtesy  of  Prof.  Victor  de  Lorenzo,  CNB,  Madrid).  ChiA  
is   an   industrially   relevant   enzyme   for   biotechnology   applications  
[34].   The   chitinase   was   fused   either   N-­‐‑   or   C-­‐‑   terminally   to   the  
nanobody   in   the   pK:LppOmpA-­‐‑NB   construct,   and   N-­‐‑terminally   to  
the   nanobody   in   the   pK:NB-­‐‑C-­‐‑IgAP   construct,   resulting   in   a   total  
passenger   size   of   72   kDa   (fig   3a).   The   proteins   were   subsequently  
produced   in   E.   coli   BL21(DE3)   and   surface   exposure   was   assayed  
using  GFP  as  described  above.  Successful  display  was  confirmed  by  
in-­‐‑gel  fluorescence  (fig  3b),  and  whole  cell  fluorescence  (fig  3c).  This  
demonstrated  that  the  nanobody  was  fully  functional  and  binding  its  
antigen   GFP   also   when   fused   to   another,   large   protein,   and   even  
when   sandwiched   in-­‐‑between   two   proteins.   As   for   the   initial  
nanobody   constructs,   significant   differences   in   display   efficiency  
were  observed  as  an  effect  of  anchor  usage.   Interestingly,   fusing  the  
chitinase   to   the   nanobody   considerably   increased   display   efficiency  
for   both   the  LppOmpA-­‐‑anchor   and  C-­‐‑IgAP   (fig   3d-­‐‑e).   Furthermore,  
the  position  of   the  nanobody   in   the  construct   influenced  the  surface  
presentation;   pK:LppOmpA-­‐‑NB-­‐‑ChiA   showed   substantially   higher  
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Figure  3.  Functional  display  of  Chitinase  A  using  both  display  anchors.  A.  
Protein   schemes   for   Chitinase  A-­‐‑NB   fusions.   The   ChiA   protein  was   fused  
either   in-­‐‑between  OmpA  and  NB,   or  C-­‐‑terminally   to  LppOmpA-­‐‑NB.  With  
the  C-­‐‑IgAP   anchor,  ChiA  was   fused  N-­‐‑terminally   to  NB-­‐‑C-­‐‑IgAP.  B.   In-­‐‑gel  
fluorescence   of   rhamnose   titrations   of   chitinase-­‐‑nanobody   fusions,   and   in-­‐‑
gel   fluorescence   after   addition   of   proteinase   K.   The   same   amount   of   cells  
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each   of   the   chitinase-­‐‑nanobody   fusions.   Values   are   averages   of   biological  
duplicates,   error   bars   are   standard   errors.  D.  Whole   cell   fluorescence   for  
LppOmpA   constructs   with   and   without   ChiA,   induced   with   1   mM  
rhamnose.  Values  are  averages  of  biological  duplicates,  bars  show  standard  
error.   E.  Whole   cell   fluorescence   for   C-­‐‑IgAP   constructs   with   and   without  
ChiA,   induced   with   1   mM   rhamnose.   Values   are   averages   of   biological  
triplicates,   bars   show   standard   error.   F.   Specific   chitinase   activity   for  
nanobody-­‐‑   chitinase   fusions   at   two   different   inducer   concentrations,  
normalised   to   OD.   Values   are   averages   of   biological   duplicates,   bars   are  
standard   errors.   Lppss:   lpp   signal   sequence;   pelBss:   pelB   signal   sequence;  
OmpA:  Outer  membrane  protein  A;  ChiA:  Chitinase  A;  NB:  nanobody;  C-­‐‑
IgAP:  C-­‐‑terminal  of  IgA  protease.    
  
  
The   rhamnose   promoter   is   highly   titratable   [35,   36].   To   test   this  
tunability   in  our   system,  we  varied   inducer   concentration   from  0   to  
10  mM  rhamnose  (fig  3b-­‐‑c).  Based  on  in-­‐‑gel  fluorescence  analysis  and  
plate   reader   data,   increasing   the   concentration   of   rhamnose   led   to  
higher   protein   production,   but   the   effect   levelled   off   at   higher  
concentrations.   The   LppOmpA   constructs   showed   better   tunability  
by   rhamnose   than   the   autotransporter   version,   which   was   largely  
unaffected  by  inducer  concentration.    
  
To   confirm   the   functionality   of   the   surface   displayed   enzyme,  
chitinolytic  activity  was  assayed  in  vivo,  for  the  same  amount  of  cells,  
at  two  different  inducer  concentrations,  0.2  mM  and  2  mM  rhamnose  
(fig  3f).  The  chitinase  was  active  with  all   surface  display  constructs,  
with   higher   activity   for   the   LppOmpA   fusions   pK:LppOmpA-­‐‑NB-­‐‑
ChiA   (156   ±   25   mU/ml/OD   at   2   mM   rhamnose   induction)   and  
pK:LppOmpA-­‐‑   ChiA-­‐‑NB   (108   ±   11   mU/ml/OD)   than   for   the  
autotransporter   variant   pK:ChiA-­‐‑NB-­‐‑C-­‐‑IgAP   (77   ±   7   mU/ml/OD).  
Activity   levels   correlated   well   with   GFP-­‐‑based   expression   data  
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measured   with   plate   reader   and   in-­‐‑gel   fluorescence   for   the  
LppOmpA  fusions,  with  a  doubling  of  fluorescence  corresponding  to  
a   doubling   in   activity   (fig   3c   and   3f).   This   correspondence   between  
enzymatic   activity   and   fluorescence   data   showed   that   the   NB:GFP  
assay   gives   a   reliable   indication   of   how  much   functional   protein   is  
displayed  on  the  cell  surface  for  LppOmpA.  For  pK:ChiA-­‐‑NB-­‐‑C-­‐‑IgAP  
the   correlation   is   weaker,   with   activity   levels   varying   more   than  
fluorescence   levels   for   the   two   inducer   concentrations.   Controls  
without  chitinase  showed  no  background  activity.    
  
Flow  cytometry  analysis  reveals  two  populations  of  cells  and  
confirms  varying  display  efficiency    
To   study   the   display   efficiency   on   a   single-­‐‑cell   level,   cells   were  
analysed   by   flow   cytometry   (fig   2g   and   fig   4).   This   revealed   two  
disparate   populations   of   cells,   both   when   using   the   LppOmpA  
anchor  and  the  C-­‐‑  IgAP  anchor  (fig  4a  and  b,  respectively),  with  only  
one   of   the   populations   presenting   the   protein   fusion   on   the   cell  
surface,   as   previously   observed   [10,   37].   The   proportion   of  
fluorescent  cells  varied  from  only  15.3%  for  pK:NB-­‐‑C-­‐‑IgAP  to  41.9%  
for   pK:LppOmpA-­‐‑ChiA-­‐‑NB   (fig   4c).   Interestingly,   the   relative  
amount  of  displayers  was  virtually  identical  for  pK:LppOmpA-­‐‑ChiA-­‐‑
NB   (41.9%)   and   pK:LppOmpA-­‐‑   NB-­‐‑ChiA   (41.8%),   but   the   mean  
fluorescence   as   measured   by   flow   cytometry   is   2.5-­‐‑fold   higher   for  
pK:LppOmpA-­‐‑NB-­‐‑ChiA,  in  line  with  whole-­‐‑cell  fluorescence  (fig  3c).  
Thus,   the   pK:LppOmpA-­‐‑NB-­‐‑   ChiA   population   contained   cells   that  
had  very  high  fluorescence  per  cell,  while  the  fluorescent  population  
was  more  homogeneous  in  the  case  of  pK:LppOmpA-­‐‑ChiA-­‐‑NB.  This  
highlights   the   different   levels   of   information   obtained   from   the  
different   methods,   and   that   high   protein   titers   not   necessarily  
correspond  to  high  production  per  cell.  The  strikingly  positive  effect  
of  Chitinase  A  on  protein  display   levels  was  also  evident  with   flow  
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cytometry,  with   the  proportion  of   fluorescent   cells   increasing  by  up  
to  86%  when  adding  Chitinase  A  to   the  LppOmpA  fusion  (compare  
fig   2g   and   4a),   and   by   103%   for   the   corresponding   C-­‐‑IgAP   fusion  
proteins  (compare  fig  2g  and  4b).  Under  control  of  the  Ptrc  promoter,  
the  LppOmpA-­‐‑NB  construct  formed  a  single  population  (Additional  
file  2:  Fig  S2).    
Figure  4.  FACS-­‐‑analysis  of  Chitinase  A-­‐‑nanobody  surface  display  fusions.  
Fluorescence  was  measured  by  flow  cytometry  3  h  after  rhamnose  induction  
of  cells  in  exponential  growth  followed  by  20  min  incubation  with  purified  
GFP,   and   two   steps   of   washing.   A.   Chitinase-­‐‑nanobody   fusions   surface  
displayed   with   LppOmpA,   with   (green)   and   without   (red)   rhamnose  
induction.   B.   Chitinase-­‐‑nanobody   fusion   displayed   with   C-­‐‑IgAP,   with  
(green)   and   without   (red)   rhamnose   induction.   C.   Overlays   of   the   flow  
cytometry  profiles  for  all  fusions,  with  rhamnose  induction:  LppOmpA-­‐‑NB,  
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Nanobody:GFP   platform   allows   systematic   study   of   signal  
peptide  effects  on  surface  display    
With  the  assay  running  in  a  convenient  96-­‐‑well  format,  it  is  possible  
to   study   how   different   parameters   affect   surface   display   in   a   high-­‐‑
throughput  manner.  As  proof  of  concept,  we  studied  the  effect  of  the  
signal   sequence   on   display   efficiency.   The   challenging-­‐‑to-­‐‑display  
ChiA-­‐‑NB-­‐‑C-­‐‑IgAP   fusion   was   cloned   into   a   set   of   nine   low-­‐‑copy  
pD881   plasmids,   identical   except   for   harbouring   different   signal  
peptides   responsible   for   targeting   the   protein   to   the   periplasm.  We  
subsequently  surveyed  protein  display  using  the  NB:GFP  assay,  and  
compared  whole-­‐‑cell  fluorescence  values  for  the  different  constructs.  
Large  variation  was  observed  between  the  different  signal  sequences  
(fig   5a).   Several   of   the   signal   peptides   showed   very   low   display  
capacity,   in   particular   torA   for  which   induced   cells  were   negligibly  
fluorescent.   The   signal   peptides   dsbA,   ompA,   ompC,   ompT,   pelB,  
sufl   and   torT  gave  higher   fluorescence  values,  whereas  glll   resulted  
in   approximately   twice   as   high   fluorescence   as   the   other   signal  
peptides.  Notably,  pelB  is  the  signal  peptide  used  in  the  original  pK  
construct,  but,  based  on  this  result,  it  is  only  mediocre  in  comparison  
with  glll.  Therefore  we  followed  up  on  this  experiment  by  replacing  
the   pelB   signal   peptide   in   the   pK   backbone   with   the   gIII   signal  
peptide   and   analysed   protein   production.   In   this   high   copy   vector,  
the   advantage   of   gIII   over   pelB   disappeared   (fig   5b).   A   signal  
sequence   library  was   likewise   constructed   for   the  LppOmpA-­‐‑ChiA-­‐‑
NB  fusion.  Again,   the  various  signal  sequences  resulted   in  variation  
of   enzyme   display   but   without   any   exceptional   high-­‐‑displayer  
(Additional  file  3:  Fig  S3).    
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Figure   5.   Evaluation   of   a   signal   sequence   library   on   display   levels   of  
nanobody-­‐‑fused   chitinase   (ChiA-­‐‑NB-­‐‑C-­‐‑   IgAP).   A.   The   ChiA-­‐‑NB-­‐‑C-­‐‑IgAP  
fusion   was   cloned   into   a   set   of   nine   vectors   containing   different   signal  
peptides  for  directing  the  polypeptide  to  the  periplasm.  Fluorescence  values  
were  measured   in  a  plate   reader.   Significant  variation  among   the  different  
peptides   was   observed,   with   gIII   showing   the   highest   signal.   Values   are  
averages  of  biological  triplicates,  bars  standard  error.  B.  Comparison  of  gIII  
and  pelB   signal   peptides   in   the   pK   backbone.  Values   are   averages   of   four  




Bacterial   surface   display   of   enzymatically   active   proteins   is   a  
promising   strategy   to   engineer   whole-­‐‑cell   catalysts,   enabling  
simplification   of   production   procedures   as   well   as   downstream  
processes.   Even   though   many   surface   display   systems   have   been  
successfully   employed   since   the   first   bacterial   anchors   were  
developed   in   the   1980s   (reviewed   in   [4]),   unpredictable,   cargo-­‐‑
dependent   effects   hinder   rational   design   and   optimization,   as  
exemplified   by   Nicolay   et   al.   who   reported   failure   to   display   a  
number   of   passenger   domains   with   a   previously   characterised  
autotransporter  [8].    
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In   this   study   we   used   a   camelid-­‐‑derived   nanobody   to   construct   a  
quantitative,  inexpensive,  and  robust  assay  that  allows  for  easy  GFP-­‐‑
based   screening   and   optimization   of   surface   display   systems   in   a  
high-­‐‑   throughput   manner.   By   making   use   of   the   tight   association  
between  a   surface-­‐‑presented  nanobody  and  externally   applied  GFP,  
we   addressed   a   need   for   a   fluorescence-­‐‑based   assay   for   surface  
display,  underscored  by   the  avid  use  of   two-­‐‑step  antibody   labelling  
procedures   in   the   literature   [10–12].   Furthermore,   we   demonstrate  
that   the   NB:GFP   platform   is   compatible   with   all   techniques  
commonly   associated  with   fluorescent   tags:  whole   cell   fluorescence  
measurements,   in-­‐‑gel   fluorescence   analysis,   flow   cytometry,   and  
microscopy.  Previously  established  techniques  for  fluorescence-­‐‑based  
evaluation   of   surface   display   include   the   use   of   small   peptide   tags,  
such   as   FLAG   and   myc   [38],   and   of   domains   of   staphylococcal  
protein   A   and   streptococcal   protein   G   [39],   followed   by   detection  
with   antibodies.   In   relation   to   these,   the   NB:GFP   platform   differs  
especially  in  that  it  is  a  one-­‐‑step  procedure  enabling  all  down-­‐‑stream  
analyses,   in   particular   simplifying   analysis   of   samples   on   protein  
gels.   Furthermore,   costs   for   especially   monoclonal   antibodies   are  
high,  whereas  both  NB  and  GFP  are  easily  produced  in  E.  coli.    
  
Both   of   the   two   anchors   used,   LppOmpA   and   C-­‐‑IgAP,   enabled  
functional   display   of   the   nanobody,   although   the   efficiency   was  
higher  with  LppOmpA  in  terms  of  total  protein  production  as  well  as  
display   efficiency   across   a   population   of   cells.   The   basis   for   the  
difference  in  fluorescence  could  alternatively  be  low  expression  of  the  
C-­‐‑IgAP  construct  gene,  poor   folding  of   the  nanobody,  or  poor  GFP-­‐‑
NB   interaction   at   the   surface.   The   observed   fitness   cost   for   cells  
induced   for   NB-­‐‑C-­‐‑IgAP   production,   however,   indicates   that   the  
explanation  is  meagre  protein  display,  and  points  to  LppOmpA  as  a  
more  robust  anchor  in  our  system.  While  autotransporters  have  been  
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reported  as  successful  display  anchors  in  many  cases,  our  results  are  
consistent   with   several   studies   where   negative   effects   of  
autotransporter  anchors  were  observed,  with  regards  to  cell  viability  
[40],   membrane   integrity   [41]   and   ultimately   on   surface   display  
efficacy  [8].    
  
Although   nanobodies   are   pharmaceutically   interesting   display  
targets   in   their  own  right   (recently  displayed   in  Gram  positives   [42]  
and  E.   coli   [43],   and   routinely   selected   through  phage-­‐‑display   [44]),  
our   goal   was   to   use   the   nanobody   as   a   molecular   biology   tool   for  
detection  of  other  passenger-­‐‑protein  fusions.  We  applied  the  NB:GFP  
platform   for   surface   display   of   the   industrially   relevant   enzyme  
Chitinase  A   from  S.  marcescens   [45,   46].   Its   substrate   chitin   is  one  of  
the  most   abundant  biomasses  on  Earth   and  degradation  of   chitin   is  
attractive  for  e.g.  bioethanol  production,  production  of  new  materials  
and  in  the  food  industry  [34].    
  
Importantly,  the  nanobody  was  readily  binding  GFP  independent  of  
its  position  in  the  fusion  protein:  when  displayed  immediately  linked  
to   outer   membrane   proteins   close   to   the   cell   surface;   when   being  
placed   further   away   from   the   surface   as   fusions   to   the   functional  
Chitinase   A   enzyme   domain;   and   when   being   sandwiched   in  
between   the   cell   anchor   and   Chitinase   A.   This   suggests   that   the  
nanobody  is  a  robust   fusion  partner,  also  suitable  for  more  complex  
designs   such   as   multi-­‐‑enzyme   pathways.   While   GFP   itself   can   be  
displayed   on   the   cell   surface   [10,   47,   48],   the   complementary  
approach  of  displaying  the  nanobody  and  detecting  it  with  externally  
added   GFP   circumvents   the   problem   of   false   positives,   since   only  
binding   with   nanobody   presented   at   the   cell   surface   will   yield   a  
fluorescent  signal.    
  
	   121	  
Interestingly,   adding   Chitinase   A   to   our   protein   fusions   markedly  
enhanced  display  levels  in  spite  of  more  than  doubling  the  size  of  the  
fusion   protein.   A   possible   alternative   explanation   of   the   observed  
increase  in  fluorescence  is  that  the  nanobody  became  more  accessible  
to  GFP  when  fused  to  ChiA  -­‐‑  this,  however,  seems  unlikely  given  that  
the   nanobody   is   sandwiched   in-­‐‑between   two   proteins   in   the   best  
performing  constructs.  The  apparent  correlation  between  chitinolytic  
activity  and  GFP  signal  further  supports  an  actual   increased  display  
level.   Interactions   between   a   passenger   domain   and   the   cell  
membrane   have   been   suggested   to   be   an   important   factor   for  
translocation,  and  one  could  speculate  that  ChiA  similarly  stimulates  
translocation   of   its   fusion   partner   [49].   In   general,   saturation   of   the  
transport  machinery  responsible  for  translocating  proteins  to  the  cell  
surface  is  a  major  bottleneck  when  overexpressing  membrane  protein  
genes  [22].  Since  Chitinase  A  is  naturally  secreted  in  its  native  gram-­‐‑
negative   host,   in   contrast   to   the   nanobody,   it   is   likely   that   the  
biochemical  properties  of  the  protein  are  well  suited  for  translocation  
in  E.  coli  as  well.  The  chitinase  was  active  in  all  fusion  combinations,  
and   activity   levels   corresponded   well   with   fluorescence   data   for  
LppOmpA,  whereas   correlation  was  weaker   for   the   autotransporter  
version.  This  may  be  explained  by  some  of  the  protein  being  halted  in  
the  periplasm,  where  the  assay  substrate  might  be  accessible.  This  is  
in   line   with   the   observed   fitness   cost   of   NB-­‐‑C-­‐‑IgAP   production.  
Although   varying   inducer   concentrations   made   it   possible   to   tune  
display  to  a  certain  degree,  the  increase  in  display  eventually  levelled  
off   for   the   LppOmpA   fusions,   and   C-­‐‑IgAP   display   was   only  
marginally   affected.   This   fits   well   with   previous   reports   that  




The   versatility   of   the   NB:GFP   platform   allowed   us   to   study   the  
population   behaviour   by   flow   cytometric   analyses.   The   LppOmpA  
fusions  with  Chitinase  A  constituted  either  a  relatively  homogeneous  
population   of   medium-­‐‑expressers   (fig   4a,   left   panel),   or   a   slightly  
more   heterogeneous   population   with   some   very   highly   expressing  
cells   (fig   4a,   right   panel).   This   demonstrates   how   the   evaluation   of  
production   efficiency  may  vary  dependent  on   the   read-­‐‑out  method,  
and   how   the   versatility   of   the   NB:GFP   platform   allows   for  
optimisation   of   several   important   parameters.   This  will   likely   be   of  
high   value   for   development   of   robust   whole-­‐‑cell   catalysts.   The  
occurrence  of  two  populations  can  in  the  context  of  the  present  study  
be   attributed   to   the   rhamnose   promoter:   when   expressing   the  
LppOmpA-­‐‑NB   construct   under   control   of   the   IPTG-­‐‑inducible   Ptrc  
promoter,   we   observed   an   almost   homogeneous   population  
distribution  (Additional  file  2:  Fig  S2).    
  
We  have  used  the  platform  to  evaluate  one  of  the  key  parameters  for  
secretion,   the   N-­‐‑terminal   signal   sequence   responsible   for   targeting  
the   nascent   polypeptide   to   the   periplasm   prior   to   its   translocation  
across   the   outer  membrane   [50].   This  demonstrated   the  potential   of  
the  NB:GFP  platform  to  study  the  effect  of  different  signal  peptides  in  
surface   presentation,   in   a   multi-­‐‑format   setup.   Fluorescence   signals  
varied  more   than   6-­‐‑fold   between   the   lowest   and   highest   displayed  
constructs.   In   consistence  with  previous   reports   [51],   this  highlights  
the   importance   of   systematic   process   optimisation   for   surface  
display,   and   shows   the   feasibility  of   the  developed   technology.  The  
negligibly   low  torA  signal   is  not  unexpected  since   this  peptide  only  
directs  export  of   fully   folded  protein   [52].  Compared   to   the  original  
pK   construct,   all   tested   signal   sequences   gave   a   lower   fluorescence  
signal,  which   is   likely   explained   by   the   fact   that   pK   is   a   high-­‐‑copy  
plasmid  whereas   the   signal   peptide   library   backbone   is   a   low-­‐‑copy  
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vector.   Inserted   into  pK,  however,  gIII  no   longer  excelled  compared  
to  pelB.  This  shows  that  surface  display  is  dependent  on  an  intricate  
mesh   of   mechanisms,   where   plasmid   copy   number   and   signal  
sequence   are   two   important,   interdependent   parameters,   making  
display  optimisation  a  complex  process.    
  
The  NB:GFP   system   is   a   rapid   assay   for   quantitative   assessment   of  
surface   display,   making   use   of   GFP   that   is   easily   produced   and  
purified   in  E.  coli.  The  platform  has   the  potential   to   ease   systematic  
studies   of   surface   display   systems   and   drive   quick   optimisation   of  
individual   display   systems   in   a   multi-­‐‑well   format   –   however,  
optimisation   and   testing   of   the   system   for   each   individual   protein  
will   likely   be   needed.   Furthermore,   our   hope   is   that   the   NB:GFP  
platform   will   facilitate   the   fundamental   understanding   of   the  
molecular   mechanisms   behind   the   biogenesis   of   E.   coli   outer  
membrane  proteins  that  can  enable  rational  development  of  bacterial  




We   developed   an   inexpensive,   robust   and   quantitative   surface  
display   platform   that   allows   for   functional   display   of   enzymes.  
Furthermore,   we   employed   the   nanobody:GFP   platform   for   (1)  
expression   of   the   industrially   relevant   enzyme   Chitinase   A   and   (2)  
evaluation   of   a   signal   peptide   library’s   effect   on   surface   display  
through  easy  quantitative  screening.    
  
Methods    
Gene  and  vector  design    
All  cloning  was  done  with  USER  fusion  (as  described  in  Cavaleiro  et  
al.  [53])  unless  otherwise  specified,  into  the  high-­‐‑copy  plasmid  vector  
	  124	  
pK  (described  in  [33])  and  is  outlined  in  Additional  file  4:  Fig  S4.  C-­‐‑  
IgAP  sequence  and  the  N-­‐‑terminal  signal  peptide  pelB  were  obtained  
from   the   de   Lorenzo   lab   [19]   and   cloned   into   pK   using   oligos   525,  
526,  527  and  528,  forming  pK:C-­‐‑IgAP.  pK:lpp-­‐‑OmpA  was  constructed  
in   several   steps:   Lpp   and   OmpA   were   amplified   from   E.   coli  K12  
MG1655   genomic   DNA   with   oligos   Lpp-­‐‑F   and   Lpp-­‐‑OmpA-­‐‑R,   and  
OmpAR   and   Lpp-­‐‑OmpA-­‐‑F,   respectively,   thereby   constructing   the  
previously  described  LppOmpA  chimera  [21].  They  were  cloned  into  
plasmid  pGFP  (described   in   [54])  using  oligos  pGFP_1  and  pGFP_2,  
creating   plasmid   pLppOmpA-­‐‑GFP.   Later,   LppOmpA-­‐‑GFP   was  
transferred   to   the   pK   vector   with   oligos   GFPgenR   and   Lpp-­‐‑F   for  
LppOmpA-­‐‑GFP   amplification,   and   oligos   525   and   526   for   opening  
pK.  Subsequently,  the  nanobody  sequence  was  ordered  as  a  G-­‐‑block  
(Genscript)   codon   optimized   for   E.   coli,   and   cloned   into   plasmid  
pGFP   with   restriction   cloning   using   XhoI   and   HindIII   sites.   The  
nanobody   was   then   cloned   C-­‐‑terminally   to   LppOmpA,   replacing  
GFP,   using   oligos   855,   856,   857   and   858,   creating   plasmid  
pK:LppOmpA-­‐‑NB.   N-­‐‑terminal   fusion   of   the   nanobody   to   the  
autotransporter   C-­‐‑IgAP,   forming   pK:NB-­‐‑C-­‐‑IgAP,   was   done   using  
oligos  1715,  1716,  1717,  and  1718.  The  Chitinase  A  gene  was  provided  
by   the   de   Lorenzo   lab,   and   was   inserted   C-­‐‑   or   N-­‐‑terminally   to  
LppOmpA  by   cloning  with   oligos   1889,   1890,   1891,   1892,   1898,   and  
1899.  pK_ChiA-­‐‑NB-­‐‑AT  was  constructed  by  cloning  with  oligos  1889,  
1895,   1898,   and   1899.   All   oligos   and   plasmids   can   be   found   in  
Additional   file   5:   Table   S1   and   Additional   file   6:   Table   S2,  
respectively.    
  
Bacterial  strains  and  culture  conditions    
Escherichia  coli  NEB5alpha  strain  (New  England  Biolabs)  was  used  for  
cloning   purposes   and  E.   coli  OneShot   BL21(DE3)   (ThermoScientific)  
were   used   for   protein   production   and   display.   All   cultures   were  
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grown   at   37°C   in   Luria   Bertoni   broth   (LB)   under   agitation,   unless  
otherwise   noted,   with   kanamycin   supplemented   to   50   µμg/ml   to  
maintain  the  pK  plasmids.    
  
Production  of  surface  displayed  proteins    
Surface   display   ORFs   were   under   the   control   of   the   rhaPBAD  
promoter.  E.   coli  BL21(DE3)   cells   containing   the   pK   surface   display  
plasmids  were  inoculated  from  overnight  culture  to  OD600  0.1  in  LB  
and   grown   at   37°C,   250-­‐‑300   rpm,   to   an   OD600   of   0.3-­‐‑0.5,   when  
protein   production   was   induced.   Induction   was   carried   out   using  
various   concentration   of   rhamnose   and   expression   of   plasmid-­‐‑
encoded  genes  was  allowed  for  3  h  at  30°C.    
  
GFP  and  NB  production  and  purification    
His-­‐‑tagged  nanobody  and  Folding  reporter  GFP  [55]  under  control  of  
the   T7   promoter   were   produced   in   E.   coli   SHuffle   (New   England  
Biolabs)   and  E.   coli  BL21   (DE3),   respectively,   by   induction  with   0.4  
mM  IPTG  for  5  h.  Cells  were  then  resuspended  in  IMAC  wash  buffer  
(50  mM  Tris-­‐‑HCl,  10  mM  imidazole,  500  mM  NaCl,  10%  glycerol  [pH  
7.5]),   lysed   by   three   passes   through   an  EmulsiFlex-­‐‑C5  homogenizer  
(Avestin)   at   10   000–15   000   psi   and   any   debris   and   unbroken   cells  
were   removed   by   centrifuging   at   18   000   g   at   4°C   for   15   min.   The  
supernatant   containing   the   proteins   of   interest   was   loaded   onto  
nickel-­‐‑  nitrilotriacetic  acid   (Ni2+-­‐‑NTA)  resin  columns   (HisTRAP)  on  
an   Äkta   Pure   system   connected   to   an   F9-­‐‑C   fraction   collector   (GE).  
The  bound  protein  was  washed  extensively  with  IMAC  wash  buffer  
and   was   subsequently   eluted   by   increasing   the   imidazole  
concentrations   to   500  mM   in   a   single   step.   The   fractions   containing  
the  protein  of  interest  were  pooled  and  stored  at  –80°C  for  nanobody,  
and  –20°C  for  GFP,  until  use.    
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Nanobody:GFP  assay    
Protein  production  was  stopped  by  pelleting  cells  via  centrifugation  
for  4  min  at  2272  g  in  a  ThermoScientific  Multifuge  X3  FR  centrifuge.  
Cells  were  then  resuspended  in  50  µμl  50  mM  Tris  buffer,  and  mixed  
with   50   µμl   0.12   mg/ml   GFP   (final   concentration   0.06   mg/ml).   Cells  
and   GFP   were   incubated   for   20   min   at   30°C   at   250-­‐‑300   rpm.  
Incubation  was   stopped   by   centrifugation   of   cells,   4  min   at   2272   g.  
Cells   were  washed   twice  with   300   µμl   50  mM   Tris   buffer,   and   then  
resuspended   in   220   µμl   50   mM   Tris   buffer   before   downstream  
analyses.    
  
GFP  signal  detection  and  OD  measurement  using  plate  reader    
200  µμl  cell  suspension  was  transferred  to  an  opaque  microtiter  plate  
(Sigma-­‐‑Aldrich)   and   GFP   signal   was   read   in   a   SynergyMx   plate  
reader  (BioTek)  at  gain  80.  40  µμl  cells  were  then  transferred  to  160  µμl  
50  mM  Tris  buffer  (1/5x  dilution)  in  a  transparent  microplate  (Greiner  
Bio-­‐‑One)  and  optical  density  at  600  nm  was  measured.    
  
SDS-­‐‑PAGE  analysis    
Cells  were  resuspended  to  a  concentration  of  0.05  ODU/µμl  and  10  µμl  
were  mixed  with  5  µμl  2x  Laemmli  sample  buffer  and  0.5  µμl  benzonase  
nuclease   (≥250   units/µμl,   Sigma),   after   which   the   whole   sample   was  
loaded   onto   a   4-­‐‑20%   Mini-­‐‑PROTEAN®   TGXTM   gel   (Bio-­‐‑Rad)   and  
run   for   35  min   at   150V.   Fluorescent   protein   bands   were   visualised  
with   the  G:Box  bioimager   (Syngene)  using  UV-­‐‑light   filter,   and   total  
protein  was  assessed  by  staining  with  InstantBlue  (Expedeon).    
  
Fluorescence  microscopy    
3   µμl   cells   were   pipetted   onto   Poly-­‐‑prep   microscopy   slides   (Sigma)  
and   studied   in   a   Leica   DM4000B   fluorescence   microscope   at   100x  
magnification,   using   Leica   Application   Suite   v4.0   for   capturing  
	   127	  
images.  The  GFP  fluorophore  was  excited  and  signal  detected  using  
an  excitation  filter  with  bandpass  470/40  and  a  suppression  filter  with  
bandpass  525/50.    
  
Proteinase  K  accessibility  assay    
Cells   were   harvested   and   resuspended   in   50   µμl   PBS   buffer   before  
adding   1.5   µμl   Proteinase   K   (final   concentration   0.58   mg/ml)  
(ThermoScientific).  Samples  were  incubated  for  30  min  at  37°C,  after  
which   the   accessibility   was   assessed   by   carrying   out   the   NB:GFP  
assay   and   analysing   samples   on   SDS-­‐‑PAGE   as   described   above,  
starting  with  a  centrifugation  and  washing  step  to  remove  all  cleaved  
off  protein.    
  
Flow  cytometry    
Flow   cytometry   measurements   were   performed   on   a   FACS   Aria  
(Becton  Dickinson,  San  Jose,  USA)  with  488  nm  excitation  from  a  blue  
solid-­‐‑state  laser.  Cells  were  diluted  1:100  in  PBS  for  analysis.  At  least  
20,000   cells  were   collected   for   each  measurement.   FlowJo   (Treestar)  
was  used  for  data  analysis.    
  
Chitinase  activity  assay    
Chitinase   activity   was   analysed   using   the   Chitinase   Assay   Kit  
(Sigma-­‐‑Aldrich)   and   carried   out   according   to   the   manufacturer’s  
instructions.  Briefly,  cells  induced  for  chitinase  production  during  4  h  
were  resuspended   to  0.0044  OD600  units/µμl  and  10  µμl   (0.044  OD600  
units)   were   mixed   with   10   µμl   4-­‐‑Nitrophenyl   N,N’-­‐‑diacetyl-­‐‑β-­‐‑ᴅ-­‐‑
chitobioside   (1  mg/ml).  Samples  were   incubated  at  37°C   for  30  min,  
and   the   reaction  was   stopped  by  addition  of   200  µμl   39  mM  sodium  
carbonate  solution.  Cells  were  harvested,  and  200  µμl  supernatant  was  
transferred   to   a   microtiter   plate   (Greiner   Bio-­‐‑One)   and   the  
concentration   of   p-­‐‑nitrophenol   was   measured   as   absorbance   at   405  
	  128	  
nm   in   a   SynergyMx   plate   reader   (BioTek).   Specific   activity   was  
calculated  as  absorption  per  time  per  volume  against  a  p-­‐‑nitrophenol  
standard.    
  
Cloning  of  Ptrc  construct    
The   open   reading   frame   from   plasmid   pK:LppOmpA-­‐‑NB   was  
amplified   using   primers   2148   and   2152   and   USER   cloned   into   the  
linearized  backbone  pCDF_sl3m:Ptrc  made  from  amplifying  plasmid  
pCDF_sl3m:Ptrc-­‐‑GFP  [56]  with  oligos  2155  and  2197  using  the  high-­‐‑
fidelity   polymerase   Phusion   U   (ThermoScientific).   Expression   and  
detection  was   carried  out  as  described   in   the  methods   section  apart  
from:  (1)  using  1  mM  IPTG  as  final   inducer  concentration  instead  of  
L-­‐‑Rhamnose  and  (2)  supplementing  LB  growth  medium  with  a  final  
concentration  of  50  µμg/ml  spectinomycin  instead  of  kanamycin.    
  
Signal  sequence  library  cloning    
A  panel  of   signal   sequences   (dsbA,  gIII,   ompA,  ompC,  ompT,  pelB,  
sufI,   torA,   torT)   in   linearized   vector   pD881   was   acquired   from  
DNA2.0.   Cloning   of   surface   display   constructs   was   done   in   close  
agreement  with  manufacturer’s   instructions   by   treatment  with  LguI  
and   T4   DNA   Ligase   (Thermo   Scientific)   in   Tango   buffer  
supplemented  with  ATP   (Thermo  Scientific)  prior   to   transformation  
into  NEB5alpha   (New  England  Biolabs).  Oligos  2236  and  2334  were  
used   for   ChiA-­‐‑NB-­‐‑C-­‐‑IgAP   library   and   oligos   2235   and   2539   for   the  
LppOmpA-­‐‑ChiA-­‐‑NB   ditto.   The   gIII   signal   sequence   was  
subsequently   cloned   to   replace   the   pelB   peptide   in   pK:ChiA-­‐‑NB-­‐‑C-­‐‑
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Additional  files  
  
Additional  file  1:  Figure  S1  
Cells   expressing   the   NB-­‐‑C-­‐‑IgAP   construct   are   negatively   affected   by  
induction  of  protein  production.  When  induced  with  rhamnose  of  varying  
concentration,   optical   density   of   NB-­‐‑C-­‐‑IgAP   cultures   is   decreasing  
drastically,   and   to   a   similar   level   independent   of   inducer   concentration.  
LppOmpA-­‐‑  NB-­‐‑producing   cultures   are   also   affected  by   induction,   but   less  
dramatically   and   in   a   stepwise   manner.   Values   are   normalised   to   the  
average  of  uninduced  cells,  biological  triplicates,  standard  error.    






























Additional  file  2:  Figure  S2  
  
Population  distribution  with   the  Ptrc  promoter.  The  LppOmpA-­‐‑NB   fusion  
was   cloned   into   a   vector   containing   the   IPTG-­‐‑inducible  Ptrc   promoter   and  
subsequently   assayed   according   to   the   described   NB:GFP   procedure,  
followed   by   flow   cytometry   analysis.   As   depicted   in   the   figure,   a   large  
majority  of  cells  were  fluorescent.    
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Additional  file  3:  Figure  S3  
  
Variation   in   display   signal   when   fusing   OmpA-­‐‑ChiA-­‐‑NB   to   a   set   of   9  
different  signal  peptides.  The  OmpA-­‐‑ChiA-­‐‑NB  fusion  protein  was  directed  
to   the  cell   surface  by  different   signal  peptides,   leading   to  varying   levels  of  
surface  display.  Values  are  averages  of  three  biological  replicates,  error  bars  
standard  errors.    
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Additional  file  4:  Figure  S4  
  
Overview  of  plasmid  construction.  Oligos  are  given   in  bold   font,  plasmid  
names  in  regular  font  under  the  plasmid.  Colours  show  from  which  source  
each   fragment   is   amplified.   The   pK:LppOmpA-­‐‑NB   plasmid   was   made   in  
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chromosome,  whereas   pK:C-­‐‑IgAP  was   created   in   one   step.   The   nanobody  
sequence   was   ordered   as   a   G-­‐‑   block   and   restriction   cloned   into   pGFP.  
Plasmids   with   Chitinase   A   were   made   by   cloning   of   the   ChiA   gene   into  
pK:LppOmpA-­‐‑NB   and   pK:NB-­‐‑C-­‐‑IgAP.   Details   are   found   in   Gene   and  
Vector  design  in  the  Methods  section.    
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Additional  file  5:  Table  S1.  
     
Table S1. Oligos used in this study
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Additional  file  6:  Table  S2.  
  
  
Table S2. Plasmids used in this study
Plasmid Reference
pK [33]
pK:C-IgAP This study
pK:LppOmpA-GFP This study
pGFP [54]
pKa:LppOmpA-NB This study
pKa:NB-C-IgAP This study
pKa:Lpp-OmpA-NB-chiA This study
pKa:LppOmpA-chiA-NB This study
pKa:chiA-NB-C-IgAP This study
pCDF_sl3m:Ptrc [56]
pCDF_sl3m:Ptrc-LppOmpA-NB This study
pD881 DNA2.0
pD881:dsbAss-ChiA-NB-AT This study
pD881:gIIIss-ChiA-NB-AT This study
pD881:ompAss-ChiA-NB-AT This study
pD881:ompCss-ChiA-NB-AT This study
pD881:ompTss-ChiA-NB-AT This study
pD881:pelBss-ChiA-NB-AT This study
pD881:sufIss-ChiA-NB-AT This study
pD881:torAss-ChiA-NB-AT This study
pD881:torTss-ChiA-NB-AT This study
pD881:dsbAss-OmpA-ChiA-NB This study
pD881:gIIIss-OmpA-ChiA-NB This study
pD881:ompAss-OmpA-ChiA-NB This study
pD881:ompCss-OmpA-ChiA-NB This study
pD881:ompTss-OmpA-ChiA-NB This study
pD881:pelBss-OmpA-ChiA-NB This study
pD881:sufIss-OmpA-ChiA-NB This study
pD881:torAss-OmpA-ChiA-NB This study
pD881:TorT-OmpA-ChiA-NB This study
pKa_gIII_chi-NB-AT This study
